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Abstract: 
Dental caries, or cavities, is a highly prevalent disease affecting societies of different 
economic and geographic status across the globe. This disease is caused by dental decay by 
bacteria fermenting the carbohydrates in food and producing acid end-products that dissolve the 
enamel. Though there are a few different bacteria that can cause cavities, Streptococcus mutans 
is the main etiological cause of dental caries. The earliest stages of cavity formation are typically 
marked with biofilm development, in which the thick slime layer confers bacteria greater 
adherence to the enamel surface, the ability to adapt to more adverse conditions, and quorum 
sensing for communicative defense and regulation. S. mutans utilizes sugary foods, such as those 
containing sucrose, and releases acid end-products that overwhelm the buffering capacity of 
saliva and drop the pH of the oral cavity to 5.0 or lower. At this point, the enamel begins wearing 
away and cavities form.  
The ESKAPE pathogens represent another healthcare issue, as they are a group of 
bacteria that are heavily implicated in nosocomial infections and resistance to common 
antibiotics. The group is made up of the bacteria Enterococcus faecium, Staphylococcus aureus, 
Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter 
bacteria species. Due to inappropriate and excessive use of antibiotics over the years, this group 
is primarily responsible for hospital-acquired infections and treatments have been more 
challenging to come by due to their resistance mechanisms. These mechanisms include drug 
inactivation or alteration, modification of drug binding sites, reduced intracellular drug 
accumulation, and biofilm formation.  
Green tea, produced from the plant Camellia sinensis, is a popular beverage throughout 
the world, and the polyphenolic compounds of the plant have been reported to have many health 
benefits, including antimicrobial and anti-cariogenic properties. The green tea polyphenols are 
comprised of several catechins, but Epigallocatechin Gallate (EGCG) is the most abundant. Due 
to the instability of EGCG in aqueous solution and its tendency to readily oxidize, more stable 
derivatives must be studied instead. Epigallocatechin Gallate-Sterate (EGCG-S) and Palmitoyl-
Epigallocatechin Gallate (P-EGCG) are esterified, stable derivatives. P-EGCG is of particular 
interest due to its clearing by the FDA in China as a safe food preservative, and thus it could 
potentially be an oral treatment in the case of S. mutans.  
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In this study, the inhibitory effects of EGCG-S and P-EGCG at concentrations of 250 
µg/mL and 500 µg/mL were studied against the cariogenic S. mutans bacterium. These effects 
were studied through colony forming unit assays, time course studies, disk diffusion assays, and 
post-application treatments of the polyphenolic compounds. The time course study was 
performed in artificial saliva with different concentrations of sucrose (0%, 0.1%, 0.5%, and 1%) 
in order to simulate the effects of the treatment in the oral cavity filled with sugar. Four different 
mouthwash products were used in the disk diffusion assay and post-application treatment in 
order to compare the effects of the mouthwashes and P-EGCG/EGCG-S. The next objective of 
the study was to investigate the effects of the green tea polyphenol treatments on the growth of S. 
mutans. To do so, Congo Red assays, Resazurin assays, and Crystal Violet assays were 
conducted. A separate study was conducted to investigate the effects of EGCG-S against the 
ESKAPE pathogens, and disk diffusion assays and colony forming unit assays were performed. 
The disk diffusion assays were conducted synergistically with the tea polyphenolic compounds 
and several antibiotics in order to study if the effects of the antibiotics could be made more 
potent by adding EGCG-S. 
The results of the study of S. mutans growth suggests that EGCG-S and P-EGCG do 
inhibit the growth, but with mixed effectiveness. This treatment is comparable to the 
mouthwashes, although Chlorohexidine appears to be the most effective. S. mutans biofilm 
formation was inhibited by P-EGCG in the Congo Red assay, but the results of the Resazurin and 
Crystal Violet assays were inconsistent and inconclusive due to apparent cloudiness and 
precipitation. EGCG-S appeared to inhibit the growth of the ESKAPE pathogens as evidenced in 
the colony forming unit assay, although the degree of inhibition was mixed among organisms 
and concentrations of EGCG-S. The disk diffusion assay demonstrated that EGCG-S made the 
ESKAPE pathogens more sensitive to several of the antibiotics. Overall, the study suggests that 
P-EGCG and EGCG-S are effective in inhibiting the growth of S. mutans and the ESKAPE 
pathogens, but future studies must be conducted in order to ascertain the degree of inhibition and 
its effectiveness in synergistic treatment with mouthwashes/antibiotics.  
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INTRODUCTION 
a. Dental Caries 
Dental caries is a highly prevalent, multifactorial disease affecting societies of different 
economic and geographic status throughout the world (Gao et al., 2016). This disease is one of 
the costliest as well, and though it typically does not have mortality implications, it is a 
significant issue for health service providers and proper oral health (Forssten et al., 2010). Dental 
caries, more commonly referred to as cavities, is dental decay caused by bacteria fermenting 
carbohydrates in foods, producing acid as an end product and subsequently dissolving the enamel 
of the oral cavity (Featherstone, 2008). Tooth decay is most problematic in undeveloped and 
underprivileged areas, but it is also highly common amongst privileged societies as a result of 
diets high in carbohydrates, including sucrose (Marsh, 2004; Downer et al., 2005). Food 
industries have been mass producing processed foods due to technological advances, and these 
foods are often loaded with sugar to make the foods more appetizing. Dental caries is the most 
common of all childhood diseases and is estimated to occur five times more frequently than 
asthma, which is the second most common illness in children (Peterson et al., 2013). There are 
several factors which contribute to the formation of dental caries, including diet and the level of 
immune response, but the most influential factor is the acidity of the oral cavity induced by the 
microbial flora (Taylor et al., 2005). The oral cavity typically maintains a relatively neutral pH of 
approximately 6.8, and cavity development typically arises when the cavity becomes more 
acidic, which ultimately promotes the demineralization of the enamel and results in decay 
(Aframian et al., 2006).  
The issue of dental caries in the world cannot be understated, as it is extremely prominent 
amongst all ages, sexes, and classes. According to the World Health Organization, 60-90% of 
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children and approximately 100% of adults are victims to this disease worldwide (Gao et al., 
2016). The DMFS (decay-missing-filled-surface) index describes the state of dental caries in an 
individual and has been a key measure of dental decay for the past 70 years. The DMFS ranges 
from 0 to 148 with the higher values correlating to worse oral health. Research conducted on oral 
health demonstrated that 32 children participating in a study consuming over 163 grams of sugar 
daily developed a score of 5 on the index, whereas another group of 32 children consuming less 
than 78 grams of sugar daily scored a 3.2 on the DMFS index within a two-year period (Rugg-
Gunn et al., 1984). This study is one of several suggesting that sugar intake is strongly correlated 
to the development of dental caries. Tooth brushing is one of the most widely accepted and 
effective methods for preventing the formation of dental caries, and several studies have shown a 
strong correlation between the frequency of brushing and the development of caries (Mclaren et 
al., 2016; Tinanoff., 2017). However, individual brushing techniques are variable among 
different social positions and education levels. One study demonstrated that an individual’s 
education level is correlated to his or her oral condition (Rebelo et al., 2015). Similarly, an 
individual’s net income may also play a factor in dental cavity formation, as lower-income 
demographics displayed higher cavity rates than higher-income groups (Nomura et al., 2002). 
There is a direct link between personal oral hygiene and cavity formation, and those with greater 
health education and greater wealth are better equipped to properly take care of their oral health.  
The increase in acidity of the oral cavity leading to dental caries pathogenesis begins with 
the production of a biofilm and includes several steps. The biofilm, which is a slime layer 
composed of millions of bacterial cells, shares many properties with dental plaque and is formed 
in a three-stage process: docking, locking and maturation (Forssten et al., 2010). In the initial 
docking stage, the first bacteria adhere to the tooth surface. In the second step, the bacteria 
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encase themselves into an extracellular matrix and then transition to the final stage of the process 
where bacterium multiply into high cell densities (Kolenbrander et al., 2007).  Biofilm formation 
provides an advantage to bacteria, as it renders them capable of adjusting to various 
environments and increases their rates of adherence, conjugation, and growth, as well as 
allowing for a process of communication between bacterial cells termed quorum sensing (Saini 
et al., 2011). This method of communication has conferred bacteria the ability to adapt to and 
survive fluctuations in their environments, while also allowing them to promote their 
pathogenicity through the upregulation of virulence factors (Cvitkovitch et al., 2003).  The 
biofilm can grow exponentially thicker and form dental plaque, which can provide a site for the 
colonization and growth of many bacterial species, particularly Streptococcus mutans (Forssten 
et al., 2010). This bacterium is a gram-positive, facultative anaerobic cocci that is common in the 
oral cavity and is one of the main etiological causes of dental caries, partly due to its ability to 
metabolize sucrose at a significantly faster rate than other organisms (Forssten et al., 2010; Oda 
et al., 2015; Loesche, 1986; Minah et al., 1977). S. mutans is most effective at temperatures 
between 18-40°C and is an α-hemolytic streptococci species with eight stereotypes, thick cell 
walls, and a propensity to aggregate in pairs of short chains (Ajdic et al., 2002). This bacterium 
contains circular DNA and encompasses three distinct plasmids that confer resistance to 
antibiotics and heavy metals, produce bacteriocin, and have mechanisms for conjugation-like 
transfer activities (Shigeyuki et al., 1986). As a gram-positive bacterium, the quorum-sensing 
system of S. mutans is made up of a signal peptide, a membrane-bound histidine kinase sensor, 
and an intracellular response regulator which control several physiological functions, including 
competence development and gene transfer in S. mutans (Cvitkovitch et al., 2003). The quorum 
sensing capabilities of S. mutans may also play a critical role in the development of biofilm as 
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well, which allows S. mutans to effectively combat adverse environmental conditions and host 
defense mechanisms.  Typically, the appearance of S. mutans in the oral cavity is followed by the 
formation of dental caries after 6-24 months (Forssten et al., 2010).  
Many of our dietary options across the globe utilize carbohydrates, and these 
carbohydrates, particularly sucrose, are one of the main reasons for the high cavity rate in 
developed countries (Sheiham, 1984). These dietary carbohydrates result in the production of 
additional acid which may exceed both the ability of saliva to expunge acid end-products and the 
neutralizing capability of the salivary/plaque buffer system (Trahan et al., 1985). This leads to 
more frequent acidification of the plaque. Sugars, like sucrose, feed the bacteria in our oral 
cavity and utilize it to produce glucosyltransferases. Glucosyltransferase produced by S. mutans 
plays an essential role in the virulent dental plaque development and is also vital in the formation 
of extracellular polysaccharides, namely glucans from sucrose, which allow for bacterial 
adhesion to the tooth enamel and to each other (Krzyściak et al., 2013). Because sucrose is a 
low-molecular-weight disaccharide, it can be rapidly fermented and utilized by the plaque 
microbes, especially S. mutans. The process of the fermentation of the sucrose causes a drastic 
drop in the pH to 5.0 or lower in the oral cavity due to the release of acid end products such as 
lactic acid (Loesche, 1996). Typically, sucrose ingestion is met with sufficient saliva which acts 
as a buffer to prevent pH and maintain the pH of the oral cavity. Saliva typically reduces the 
incidence of cavities in a multitude of ways, such as through action as a mechanical cleansing 
agent that prevents plaque build-up, by reducing the solubility of enamel with calcium, 
phosphate and fluoride ions, and by acting as a buffer against the acid end-products produced by 
cariogenic bacteria (Mandel, 1974). The acid end-products of carbohydrate fermentation by 
bacteria like S. mutans results in an increase in free hydrogen ions in the oral cavity, which 
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lowers the pH. Saliva contains bicarbonate ions and the enzyme carbonic anhydrase, which 
catalyzes the reaction between the hydrogen ions and the bicarbonate ions. As this reaction 
continues to occur, resulting in water and carbon dioxide gas end products, the pH rises and the 
environment returns to its neutral pH levels (Makawi et al., 2017). However, it has been 
discovered that it is not the content or quantity of carbohydrates in a meal that necessarily 
dictates cavity formation, but also the frequency of their intake (Krzyściak et al., 2013). When 
the pH of the plaque decreases to approximately 5.0 or lower, the salivary buffers are rendered 
ineffective, lactic acid diffuses into the tooth, the enamel begins to erode, and calcium and 
phosphate ions are released from the sites beneath the enamel. Though the saliva typically 
replenishes these minerals and acts as a buffer against the acid, frequent consumption of 
carbohydrates, particularly sucrose, prolongs the time period in which the plaque is acidic and 
thus overwhelms the salivary buffer (Loesche, 1996).   
In addition to extracellular polysaccharides, many plaque bacteria like S. mutans produce 
intracellular polysaccharides from various sugars. In the absence of exogenous sugar, S. mutans 
may use these stored intracellular polysaccharides as a means of initiating its pathogenicity 
(Berman et al., 1967; Durso et al., 2014). The pathogenesis of this bacterium induces acid 
production in which the pH of dental plaque drops below 5.0, and thus S. mutans must be able to 
adapt to these conditions and become tolerant of its environment (Bender et al., 1986; Grisworld 
et al., 2004). S. mutans utilizes several mechanisms for increased tolerance to acidity, such as 
upregulation of the DNA repair pathway and downregulation of proton penetration into the cell 
membrane, but the key feature of this bacterium’s increased acid tolerance is the membrane-
bound F1 F0 –ATPase (Quivery et al., 2001). Membrane bound F1 F0 –ATPase can maintain the 
internal pH value due to its ability to pump protons out of the cells (Bender et al., 1986).  
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b. ESKAPE pathogens 
Similarly, the ESKAPE bacteria group are also costly and present issues and concerns for 
people across the globe. ESKAPE is an acronym for a group of bacteria comprised of 
Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter 
baumannii, Pseudomonas aeruginosa, and Enterobacter bacteria species. These bacteria are 
grouped together due to their common role in life-threatening nosocomial infections, as well as 
their potential drug resistance mechanisms (Peneş et al., 2017). A 2011 survey of nosocomial 
infections in the United States reported 722,000 cases of infections leading to 75,000 patient 
fatalities (Magill et al., 2014). The number of pathogenic bacteria capable of drug resistance 
mechanisms and the potential of resistance is growing rapidly, ultimately placing a significant 
cost on healthcare systems and functions. The methicillin resistant strain of Staphylococcus 
aureus, MRSA, is one of several hospital acquired bacterial infections with new cases appearing 
outside of a hospital setting, suggesting that this antibiotic resistant strain is becoming an 
increasing threat to public health. In 2000, MRSA infections were reported in high school and 
college athletic programs, and there have been several reports of outbreaks in NFL locker rooms 
in the past 15 years. There are several mechanisms by which the ESKAPE pathogens that allow 
them to resist antibiotics, and these genes that confer this resistance may be carried on the 
chromosome, plasmid, or transposons of the bacteria (Giedraaitiene et al., 2011). The 
mechanisms by which these bacteria resist drugs include drug inactivation or alteration, 
modification and regulation of the binding sites of the antibiotics, reduction of the intracellular 
drug accumulation, and the formation of biofilm (Wright, 2005; Li, 2004; Wilson, 2014). Some 
pathogenic bacteria are becoming more resistant to antibiotics due to overuse and inappropriate 
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use and they are no longer confined to hospitals, suggesting the need for new, investigational 
alternatives.  
The ESKAPE pathogenic bacteria are among the most heavily implicated organisms in 
both nosocomial infections and their continually developing antibiotic resistance. Enterococcus 
species are gram-positive facultative anaerobes typically found in the gut of humans and animals 
(Santajit et al., 2016). Enterococcus faecalis is perhaps the most clinically relevant, as reports 
have indicated rising resistance to ampicillin and vancomycin leading to infections in healthcare 
facilities. In the Netherlands, the average case of invasive ampicillin-resistant enterococcal 
infections in university hospitals spiked from 10 infections in 1999 to 50 in 2005 per hospital 
(Top et al., 2008). S. aureus is a gram-positive, cocci bacterium that is a typical feature of skin 
flora, particularly of the nose and perineum of humans and animals (Santajit et al., 2016). 
Historically, infections induced by Staphylococcus species have been controlled effectively by 
penicillin treatment, but excessive use of these antibiotics have led to the emergence of β-
lactamase-producing Staphylococcus, with 65-85% of this species now also resistant to penicillin 
G (Bodonakik et al., 1984). Reports of MRSA emerged as recently as the 1960s, and now 25% 
of this species are comprised of the methicillin resistant strain, with the number being as high as 
50% in certain regions (Indrawattana et al., 2013). Klebsiella pneumonia, a member of the 
Enterobacteriaceae family, is a nonfastidious, gram-negative bacillus that has acquired the 
capacity for β-lactamase enzymes. These enzymes are capable of disrupting the chemical 
structure of β-lactamase antibiotics including penicillins, cephalosporins, and carbapenems, 
resulting in infections in healthcare settings (Indrawattana et al., 2013). Acinetobacter baumannii 
are widely present in the environment and are capable of persisting for a relatively long period 
on human hands, potentially causing high rates of cross contamination in nosocomial infections 
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(Houang et al., 1998). It is a gram-negative bacterium that may cause infections at a wide range 
of sites, including the urinary and respiratory tracts. Like the other ESKAPE pathogens, strains 
of this bacterium have developed resistance to several antibiotics, including colistin and 
imipenem. Pseudomonas aeruginosa is a gram-negative, rod-shaped, facultative anaerobe 
typically found in the normal gut flora that is particularly troublesome for immunocompromised 
patients (Santajit et al., 2016). Its antibacterial resistance emanates from enzyme production and 
porin change, and patients typically become infected through exogenous sources, such as through 
contact with the environment (Fukuoka et al., 1993). Enterobacter species, nonfastidious gram-
negative rods, represent the last of the ESKAPE pathogens, and they demonstrate resistance to a 
wide range of antimicrobial drugs through high levels of mutations, with the exception of 
tigecycline and colistin (Boucher et al., 2009). Due to the rising antibiotic resistance of this 
group of bacteria, it is essential that alternative solutions are found to limit the rate of nosocomial 
and exogenous infections.  
c. Green tea polyphenolic compounds 
Tea is a popular beverage throughout the world and is made from the infusion of dried 
Camellia sinensis leaves. Eastern cultures, including China and India, are known to use tea as a 
medicinal treatment based on its many health benefits. Previous studies have demonstrated that 
Camellia sinensis, particularly the non-fermented form known as green tea, has several medical 
advantages, including anti-inflammatory, antifungal, antiviral, antioxidant, anti-mutagenic, anti-
carcinogenic, anti-diabetic, protein-denaturing, and antibacterial characteristics (Biswas et al., 
2015; Hamilton-Miller., 2001; Hirasawa et al., 2002; Hirasawa and Takada., 2004; Makimura et 
al., 1993; Nakane and Ono., 1989; Nakayama et al., 1990; Otake et al., 1991; Sakanaka et al., 
1989; Wu-Yuan et al., 1988; Xu et al., 2012). Research into the topic of the remedial effects of 
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green tea have found that the benefits are likely to be a result of the polyphenolic catechins 
present in green tea, and these catechins may also play a key role in the inhibiting the growth of 
S. mutans both in vitro and in vivo (Biswas et al., 2015; Hirasawa et al., 2006; Mankovskaia et 
al., 2013). Shown in Figure 1, three specific catechins, epicatechin gallate (ECG), 
epigallocatechin (EGC), and epigallocatechin-3-gallate (EGCG), are implicated as the prominent 
factors in the antibacterial features of green tea.  
 EGCG is the most active catechin of these three, and it makes up 59% of the catechins 
found within green tea (Taylor et al., 2005). However, EGCG can be relatively unstable in 
aqueous solution and has been found to oxidize readily, and thus an esterified derivative of 
EGCG, called epigallocatechin-3-gallate-sterate (EGCG-S), has been synthesized (Chen et al., 
2009; Chen et al., 2003). Additionally, another esterified derivative of EGCG, named Palmitoyl-
epigallocatechin-3-gallate, has been approved by the FDA in China for safe consumption as a 
preservative and may have implications as an ingestible antibacterial agent. The molecular 
structures for EGCG-S and P-EGCG are shown in Figures 2 and 3, respectively These green tea 
components have been suggested to have anticariogenic effects through in vivo research in both 
animal and human participants, as well (Biswas et al., 2015; Hamilton-Miller., 2001; Xu., 2010).  
 
  
  
Figure 1. Structures of various green tea 
catechins (Hashimoto et al., 1999). 
Figure 2. Molecular structure of EGCG-S 
obtained from the Global Ingredient 
Archival System via NIH  
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 Though there have been several studies suggesting that green tea polyphenols are 
effective in reducing S. mutans and the ESKAPE pathogens, there is limited research concerning 
the efficacy of P-EGCG against S. mutans. As an FDA approved substance in China, P-EGCG 
has the potential to serve as an ingestible remedy for the cariogenic bacterium. With regards to 
the ESKAPE pathogens, the effects of EGCG-S against this group may serve as a potential 
alternative for antibiotics considering the resistance these bacteria have developed and continue 
to develop. Therefore, the objectives of this study are 1) to determine whether utilizing EGCG-S 
or P-EGCG (utilizing 250 and 500 µg/mL of both) may inhibit the growth and biofilm formation 
of S. mutans, 2) to observe if P-EGCG can limit the growth of S. mutans in artificial saliva 
containing different concentrations of sucrose, 3) to compare the effectiveness of P-EGCG and 
EGCG-S against several brands of commercial mouth wash against the growth and proliferation 
of S. mutans, 4) to study the effects of EGCG-S against the ESKAPE pathogens, 5) to study the 
effects of EGCG-S against ESKAPE pathogens compared to and synergistically with several 
antibiotics. The bacteria representing the A of the ESKAPE acronym, Acinetobacter baumannii, 
was ordered but never received by the lab, and thus the experiments conducted on the ESKAPE 
pathogens exclude this bacterium. Future studies should aim to include this bacterium.   
 
 
Figure 3. Molecular Structure of P-EGCG  
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MATERIALS & METHODS 
1) Pre/Post-Experimental Protocols 
 Prior to each experiment, all materials and media were autoclaved or exposed to 
ultraviolet light utilizing the labs in the CELS building at Montclair State University for 10 
minutes and all surfaces were cleaned with a 10% bleach solution. Following each experiment, 
the hood was exposed to ultraviolet light for 10 minutes.  
 
2) Culturing Bacteria  
 The bacteria were grown and cultured on tryptic soy agar (TSA) plates, nutrient agar 
plates, or Mueller-Hinton agar plates. The cultures were incubated at 37°C for 24 hours and were 
subsequently stored in a cold room or refrigerator set at 4°C for future experimental use. The 
stock plates were frequently restocked and replaced to ensure the bacteria were pure and 
growing, and the purity of stock cultures was also routinely checked via microscope.  
a) Bacteria Isolation  
Stock culture plates were plated through the discontinuous streaking method shown in  
Figure 4. After confirming the purity of an isolated colony of the bacteria, the remainder of 
the colony was used to make a stock culture using a continuous streaking method, as shown 
in Figure 5. Both streaking methods were then incubated overnight at 37°C, and were then 
wrapped in parafilm and stored in the refrigerator/cold room.  
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    Figure 4.  Discontinuous Streaking Method  
    (addgene.org, 2017) 
 
 
    Figure 5. The Continuous Streaking method.  
    (commons.wikimedia.org., 2011). 
 
b) Overnight cultures 
Tryptic soy broth was prepared and 10 mL were pipetted into 15 mL plastic tubes. These 
tubes were exposed to ultraviolet light for 10 minutes prior to use. Before the night of an 
experiment, the purity of the stock plates was confirmed through a simple stain. A wired loop 
or sterile cotton swab was used to inoculate a small portion of the bacteria off of the stock 
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plate into the tryptic soy broth within the plastic tube, and then the mixture was vortexed and 
mixed to ensure optimal inoculation. Next, it was placed in a shaking incubator overnight at 
250 rpm and at 37°C. Lastly, to ensure the culture remained pure overnight, the purity was 
checked with a simple stain before the start of the experiment.   
 
3) Media Preparation  
a) Tryptic Soy Broth 
 Tryptic Soy Broth from DifcoTM was prepared by adding 30 grams of medium and 1 liter 
of deionized water into a 2-liter flask. The flask was stirred with a sterile glass rod, over a hot 
plate if necessary, to ensure proper mixing of the medium and water. The solution was 
subsequently autoclaved at 121°C, and then allowed to cool. The flask was then placed into 
the refrigerated cold room at 4°C until needed. 
b) Nutrient/Mueller-Hinton/Tryptic Soy/Congo Red Agar Preparation 
Nutrient Agar from DifcoTM was prepared using 30 grams of medium and 1 liter of 
deionized water.  Mueller-Hinton Agar from DifcoTM was prepared using 38 grams of 
medium and 1 liter of deionized water.  Tryptic Soy Agar (TSA) from RemelTM was prepared 
using 40 grams of medium and 1 liter of deionized water. Tryptic Soy Agar (TSA) from 
RemelTM was prepared by mixing 40 grams of the commercial medium and 1 liter of 
deionized water. Both solutions were mixed thoroughly with a sterile glass rod, using a hot 
plate if necessary, and then autoclaved. Next, the solutions were poured into individual sterile 
plates and left to solidify. The plates were then exposed to ultraviolet light for 20 minutes. 
Lastly, they were placed back into plastic sleeves, sealed with tape, labeled, and put into the 
refrigerated cold room at 4°C until needed.   
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Congo Red Agar from Sigma-Aldrich was prepared following the protocol outlined by 
Schwartz et al (2012). Media and Congo Red were prepared intwo separate flasks and mixed 
together after being sanitized through the autoclave. The first medium contained 9.25 grams 
of Brain Heart Infusion broth medium, 12.5 grams of sucrose (5%), 5 grams of bacto agar, 
and 250 mL of deionized water. This flask was then stirred and mixed with a sterile glass 
rod, using a hot plate if necessary, until the contents were mixed homogenously. The second 
solution contained 0.4 grams of Congo Red powder (50X) and 10 mL of deionized water. 
Both preparations were autoclaved at 121°C and set aside to cool until they reached a 
temperature between 55-60°C. 5 mL of the Congo Red solution was then added to the broth 
solution and mixed thoroughly, and the solution was then pipetted in accordance to the well 
plate being used. These plates were then allowed to solidify at room temperature. Fresh 
Congo Red media was prepared prior to each experiment.  
c) Artificial Saliva preparation 
 The artificial saliva was generated within the lab following the formula listed by Klimek 
et al., 1982. The formula is as follows: 
 0.33g KH2PO4, 0.34g Na2HPO4, 1.27g KCl, 0.16g NaSCN, 0.58g NaCl, 0.17g CaCl2, 
0.16g NH4Cl, 0.2g urea, 0.03g glucose, 0.002g ascorbic acid, and 2.7g mucin dissolved in 
1000 mL distilled water. This solution maintains a pH of 7.  
d) Preparation of Green Tea Polyphenols 
 All green tea polyphenols were purchased from Camellix LCC, Augusta, GA.  
a. EGCG-S 
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  EGCG-S was prepared using 200 proof ethanol, and the stock concentrations were 
 prepared and diluted depending on the concentration needed for each experiment. The 
 calculation of the master stock solution is as follows:  
 2.5 mg/mL = 0.0025g tea EGCG-S + 1mL EtOH 
b. P-EGCG 
  P-EGCG was prepared using 200 proof ethanol, and the stock concentrations were 
 prepared and diluted depending on the concentration needed for each experiment. 
 
4) Cytological Staining 
a) Simple Stain 
 A smear preparation was performed by first sterilizing a wire loop over a flame until it 
appeared orange in color. Once the loop cooled down, so as not to kill the bacterial cells, it 
was used to obtain a small loop of bacteria from the stock culture. The loopful of bacteria 
was then inoculated onto a sterile glass slide. A drop of methylene blue dye was then placed 
on top of the smear, followed by a cover slip. The slide was then blotted with bibulous paper, 
and then observed under oil immersion at 1000X total magnification (Lee et al., 2015).  
b) Gram-Stain 
 A smear preparation was prepared using the same technique as performed for the simple 
stain. The smear was then allowed to air dry and was then covered with crystal violet dye for 
20 seconds and subsequently rinsed with deionized water. Next, the sample was covered with 
Gram’s iodine for 1 minute, exposed to Gram’s decolorizer for 10-20 seconds, and then 
washed with deionized water. The smear was then counter stained with safranin for 1 minute 
before being washed with deionized water. Lastly, a cover slip was placed upon the smear, 
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blotted with bibulous paper, and observed under oil immersion at 1000X total magnification 
(Lee et al., 2015).  
 
Study of the Effects of Lipophilic Green Tea Polyphenolic Compounds on S. mutans 
5) Monitoring the Growth of S. mutans 
a) Standard Growth Curve 
 To monitor the growth of Streptococcus mutans, a standard growth curve was performed 
over a 24-hour period. The overnight culture in tryptic soy broth was first diluted to 0.1, and 
the culture was then placed into an incubator at 37°C. Readings were taken at every hour at 
600 nm for 10 hours and a final reading taken at 24 hours. This experiment was conducted 
using a spectrophotometer.  
b) Growth Curve in different concentrations of Sucrose 
 The cariogenic effects of S. mutans has in the presence of carbohydrates in the oral cavity 
has been reported in various studies over the year, and thus a growth curve in artificial saliva 
with sucrose concentrations of 0%, 0.1%, 0.5%, and 1% was conducted. Overnight cultures 
were prepared in each of these artificial saliva conditions was diluted to an OD600 reading of 
approximately 0.1. Readings were taken every other hour at 600 nm for 10 hours and a final 
reading was taken at 24 hours. This experiment was conducted using a spectrophotometer.  
 
6) The Effect of EGCG-S and P-EGCG against the growth of S. mutans 
a) Colony Forming Units (CFU) 
A CFU assay was conducted using P-EGCG 250 µg/mL and P-EGCG 500 µg/mL. An 
overnight culture of S. mutans in tryptic soy agar and then diluted to an OD600 reading of 0.1. 
 25 
Once this reading was obtained, 90 µL of this diluted overnight culture was aliquoted to a 
new conical tube along with 10 µL of either 250 µg/mL or 500 µg/mL P-EGCG. The controls 
were prepared by adding 10 µL of diH2O to the 90 µL of the diluted overnight. These 
treatments were then left to sit for two hours. These separate treatments were then diluted to 
reach the appropriate dilutions. A 10-2 dilution was achieved by aliquoting 10 µL of this 
mixture and adding 990 µL of diH2O. Each subsequent dilution was achieved by sequestering 
10 µL of the previous dilution and adding 990 µL of diH2O. Once the correct dilutions were 
prepared, 100 µL were pipetted onto the appropriately labeled nutrient agar plate and then 
inoculated through the continuous streaking method.  
Once each plate was inoculated, they were then incubated at 37°C for 24 hours. After 24 
hours, the plates were removed from the incubator and the individual plaques on the plate 
were counted to determine the colony forming units. For plates in which there were a 
substantial amount to count, the plates were divided to make counting easier and the number 
of colonies was then multiplied to give an approximate count of the entire plate. Once the 
colony forming units of each plate was counted, the percent of inhibition of each tea 
treatment was calculated to identify the effect of the tea against S. mutans. The following 
equation was utilized: 
Percent of Inhibition = !"#$%&'()&*+"#$,)-.(-/"#$%&'()&* 0 X100 
b) Time Course Study 
A time course study was conducted in order to determine the effectiveness of the tea 
polyphenols at different time points. The time points chosen for this study were 30 seconds, 
one minute, and 5 minutes. Overnight cultures of S. mutans were prepared in artificial saliva 
of different concentrations of sucrose: 0% sucrose, 0.1% sucrose, 0.5% sucrose, and 1% 
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sucrose. Thus, there were four separate overnight cultures needed for this experiment. S. 
mutans was inoculated into 5-6 mL of each artificial saliva condition and then incubated for 
24 hours. Prior to the time course study, the overnight cultures were plated to try and 
determine the best dilution factor for the time course experiment itself. The dilution factors 
10-2 and 10-4 were selected for the experiment.  
After preparing the overnight and determining the dilution factor, 50 µL of each 
overnight culture was then centrifuged for 5 minutes at 7000 RPM in order to form a pellet in 
which the bacteria have aggregated towards the bottom of the microcentrifuge tube. After 
forming the pellet, the pellet was either resuspended in 50 µL of 250 µg/mL P-EGCG, 
corresponding to the treated samples, or 50 µL of diH2O, corresponding to the control of the 
experiment. After the pellet was resuspended in the tea, 10 µL of the treated samples were 
removed at each time point of 30 seconds, 1 minute, and 5 minutes and placed into 990 µL of 
diH2O. This dilutes the sample to a factor of 10-2. A further dilution was then conducted by 
taking 10 µL of the 10-2 dilution and adding it to 990 µL of diH2O. The same process was 
done with the control in order to get the same dilutions.  
After the proper dilutions were made, 100 µL of each sample was plated onto the 
designated nutrient agar plate. The samples were then inoculated onto each plate using 
sterile, dispensable plastic loops through the continuous streaking method, and were then 
incubated at 37°C for 24 hours. After 24 hours, the plates were removed from the incubator 
and the CFU count of each plate was determined. The CFU count was then used to determine 
the percent of inhibition of the tea at each time point. 
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c) Disk Diffusion  
 Prior to the experiment, 15 mm disks were autoclaved within a glass petri dish in order to 
sterilize them. Nutrient agar plates were then labeled and sectioned off according to the 
treatment conditions to be used in each section. S. mutans from an overnight culture were 
continuously streaked onto these plates using a sterile cotton swab. The sterile disks were 
then soaked in the antiseptic/disinfectant/tea, and then aseptic forceps were used to transfer 
the disks to the corresponding nutrient agar plate. The treatments used in this disk diffusion 
study include the commercial mouthwashes Chlorohexidine, Colgate, Dentiste Plus White, 
and Listerine, and the tea treatments were EGCG-S 250 and 500 µg/mL and P-EGCG 250 
and 500 µg/mL. The disks were placed in the center of the plate, and then the plates were 
inverted and incubated for 48 hours at 37°C. After incubation, the radius of the zone of 
inhibition was measured in millimeters using a ruler from the edge of the disk to the edge of 
the growth, as shown in Figure 6. The measurement corresponds to the ability of the 
treatment to inhibit the bacterial growth. The mouthwashes used are demonstrated in Figure 
7, and the ingredients and flavors of these mouthwashes are demonstrated in Table 1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
  Figure 6. Demonstration of a disk diffusion plate and the zone of inhibition.  
  The grey in each section represents the disk soaked in treatment, and the white  
  represents the clearing zone in which no bacteria have grown. 
  The red line represents the zone of inhibition measured in millimeters 
ZOI	(mm)	
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  Figure 7. The mouthwash brands included in this study. From left to right, 
  the mouthwashes are the 100% natural Dentiste Plus White Perfect mouthwash,  
  the commercial mouthwash brands Listerine and Colgate, and the  
  prescription rinse Chlorohexidine mouthwash.  
 
 
Mouthwash Brand Flavor Active Ingredients Inactive Ingredients 
Dentiste Plus White 
Perfect 
Mint Sage Extract, clove oil, xylitol, 
Funnel extract, Chamomile 
extract, Glycyrrhina extract, 
Vitamin C, Eucalyptus 
 
Listerine Cool Mint Eucalyptol 0.092% 
Menthol 0.042% 
Methyl Salicylate 0.060% 
Thymol 0.064% 
Water, alcohol 
(21.6%), sorbitol 
solution flavoring, 
poloxamer 407, 
benzoic acid, sodium 
saccharin, sodium 
benzoate, FD&C 
Green No. 3 
Colgate Total Gum 
Health 
Clean Mint Cetylpyridinium chloride 0.075% 
(Ceepryn) 
Ater, glycerin, 
propylene glycol, 
sorbitol, poloxamer 
407, flavor, potassium 
sorbate, citric acid, 
sodium saccharin, 
sucralose, FD&C 
green no.3 
Chlorohexidine 
Gluconate 0.12% Oral 
Rinse 
Spearmint Chlorhexidine Gluconate (1,1’-
hexamethylene bis [5-(p-
chlorophenyl) biguanide]di-D-
gluconate) 
Water, 11.6% alcohol, 
glycerin, PEG-40 
sorbitan disostearate, 
flavor, sodium 
saccharin, FD&C 
Blue no.1 
 Table 1. A list of the flavors and ingredients of the four mouthwashes used in several experiments in this study.  
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d) Post-Application of EGCG-S and P-EGCG 
A post-application study was conducted in order to determine the effect of EGCG-S and 
P-EGCG as disinfectants against S. mutans. Overnight cultures were prepared and controls 
were prepared to dilution factors of 10-4, 10-6, and 10-8 by diluting with water and the 
commercial mouthwash products were diluted to a factor of 10-2. The dilutions were prepared 
utilizing diH2O. Once the dilutions were prepared, 100 µl of each dilution was plated on TSA 
plates and then left to air dry for five minutes.  
Once the plates dried, the P-EGCG, EGCG-S, and commercial mouthwashes were added 
to the designated plates. 100 µL of P-EGCG (250 and 500 µg/mL), EGCG-S (250 and 500 
µg/mL), Chlorohexidine, Listerine, Colgate, and Dentiste Plus White were pipetted onto the 
designated plate for each treatment and the plate was air-dried for an hour afterwards. 
Following drying, the plates were incubated at 37°C for 24 hours. All plates were incubated 
at optimal temperature overnight and the CFU was counted, followed by calculation of the 
percent of inhibition. Due to the high count of CFU on certain plates, a division method was 
used to count in which the plates were divided into 16 in order to obtain a more countable 
section, and then the value of this section was multiplied by 16 in order to give an 
approximation of the total CFU value on the plates.  
 
7) Study the Effect of P-EGCG on Biofilm formation 
a) Congo Red Assay 
 Overnight cultures were prepared and diluted to 0.1 optimal density at 600 nm. 250 µL of 
the overnight of S. mutans was pipetted onto two Congo Red wells of a 24 well plate. The 
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experimental groups were prepared the same way, but the tea treatment was added as well. 
250 µg/mL and 500 µg/mL P-EGCG were used for treatment. Two wells were treated with 
50 µL of 250 µg/mL P-EGCG and another two wells were treated with 100 µL of 250 µg/mL 
P-EGCG. The same was done for 500 µg/mL P-EGCG. The Congo Red plates were then 
incubated for 4 days at 37°C. Pictures were taken after the four days to monitor the growth of 
the biofilm. The positive results were observed as dark precipitation on the red agar plates, 
and negative results were observed as a lack of change from the strong red color observed 
before inoculation.  
b) Resazurin Assay 
Overnight cultures were prepared in the four different sucrose concentrations of artificial 
saliva, and the cultures were then diluted to an absorbance range of approximately 0.3 OD at 
600nm using a spectrophotomer. The cultures were then incubated overnight at 37°C, and 
were then plated in a 48 well plate. The experiment was conducted using P-EGCG, and three 
repeating trials were prepared to test for the effects of 250 µg/mL P-EGCG, 500 µg/mL P-
EGCG, and a control using diH2O for each of the artificial saliva conditions. Following the 
set-up of the plate, it was incubated at 37°C for 3-4 days to allow for biofilm to develop. 
Following this incubation, the supernatant of each cell was removed while being cautious so 
as not to disrupt the biofilm by touching the bottom of the well with the pipette. After 
removing the supernatant, each well was rinsed with 100 µL of 10X PBS, and the supernatant 
was removed following the wash. Next, 200 µL of Resazurin working solution, prepared 
from 400 µL stock resazurin and 20 mL of PBS, was pipetted into each well. After adding the 
Resazurin working solution, the fluorescence was measured at excitation of 560 nm and 
emission of 590 nm using the multi-plate reader in order to measure the growth of biofilm.  
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c) Crystal Violet assay 
 The procedure of making the overnight culture in artificial saliva of different sucrose 
concentrations, preparing the 48 well plate, and incubating the plate for 3-4 day follows the 
protocol of the Resazurin assay. After incubating for 3-4 days, the supernatant was removed 
from each well and the wells were then washed with 250 µL of 10X PBS. The supernatant 
was removed, and 200 µL of Crystal Violet dye was then added to each well. The treatment 
was then left to sit for 30 minutes, and the Crystal Violet was subsequently removed from 
each well. The plate was then left to air-dry overnight by turning the plates upside down. The 
following day, 500 µL of acetic acid was added to each well, and the absorbance  
of the wells was measured at 595 nm in order to measure the growth of biofilm formation.  
 
Study of the Effects of Lipophilic Green Tea Polyphenolic Compounds on the ESKAPE 
pathogens 
8) Effects of EGCG-S on the growth of the ESKAPE pathogens 
a) Disk Diffusion assay  
 Prior to the experiment, 6 mm blank disks were autoclaved within a glass petri dish in 
order to sterilize them. These blank disks were used as controls throughout the experiment. 
Mueller-Hinton agar plates were then labeled and sectioned off according to the treatment 
condition to be used in each section. Cultures of the ESKAPE bacteria were prepared in 
Tryptic Soy Broth and incubated overnight at 37°, diluted to an OD600 reading of 0.1, and 
then the bacteria from each culture was continuously streaked onto the appropriate plates 
using a sterile cotton swab. Aseptic forceps were then used to place the 6 mm disks of either 
the control or the antibiotics used in the experiment. The antibiotic disks used in this 
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experiment included Erythromycin, Chloramphenicol, Penicillin, Tetracycline, Vancomycin, 
Kanamycin, Ampicillin, Streptomycin, Bacitracin, Cephalothin, and Polymyxin. After 
placing the disks in the center of each section, each disk was treated with 100 µL of 500 
µg/mL EGCG-S. The plates were then incubated for 24 hours at 37°C. Following incubation, 
the diameter of the zone of inhibition was measured in millimeters using a ruler from one 
edge of the inhibitory zone to the other. This measurement corresponds to the ability of the 
treatment to inhibit the bacterial growth. The inhibitory effect of the combination of the tea 
polyphenols and the antibiotic were compared with the effect of the individual antibiotics, 
and the percent inhibition of the tea polyphenols was calculated with the following equation: 
Percent of Inhibition = !456%&'()&*+456,)-.(-/456%&'()&* 0 X100 
b) Colony Forming Unit assay  
 A CFU assay was conducted using EGCG-S 250 µg/mL and EGCG-S 500 µg/mL. 
Overnight cultures of the ESKAPE bacteria were prepared in tryptic soy broth and then 
diluted to an OD600 reading of 0.1. Once this reading was obtained, 90 µL of this diluted 
overnight culture was aliquoted to a new conical tube along with 10 µL of either 250 µg/mL 
or 500 µg/mL EGCG-S. The controls were prepared by adding 10 µL of diH2O to the 90 µL 
of the diluted overnight. These treatments were then left to sit for two hours in order to allow 
the cells to be adequately exposed to the tea polyphenols. These separate treatments were 
then diluted to reach the instructed dilutions. A 10-2 dilution was achieved by aliquoting 10 
µL of this mixture and adding 990 µL of diH2O. Subsequent dilutions were prepared by 
either sequestering 10 µL of the previous dilution and adding 990 µL of diH2O in order to 
achieve two further dilutions or by sequestering 100 µL of the previous dilution and adding 
900 µL of diH2O to achieve one further dilution. Once the correct dilutions were prepared, 
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100 µL were pipetted onto the appropriately labeled nutrient agar plate and then inoculated 
through the continuous streaking method with a sterile cotton swab.  
 Once each plate was inoculated, they were then incubated at 37°C for 24 hours. After 24 
hours, the plates were removed from the incubator and the individual plaques on the plate 
were counted to determine the colony forming units. For plates in which there were a 
substantial amount to count, the plates were divided to make counting easier and the number 
of colonies was then multiplied to give an approximate count of the entire plate. Once the 
colony forming units of each plate was counted, the percent of inhibition of each tea 
treatment was calculated to identify the effect of the tea against S. mutans.  
 
RESULTS & DISCUSSION 
 
The Effect of EGCG-S and P-EGCG against the growth of S. mutans 
 
1) Cytological Staining 
 Simple and gram-stains were conducted in order to characterize S. mutans and identify its 
morphology and cell surface. The results of these stains are demonstrated in Figures 8 and 9. 
The simple stain confirms that the bacteria present are in fact S. mutans, as evidenced by the 
circular, cocci shape typically found in chains. The gram-stain technique showed purple-
stained cells, confirming that S. mutans is a gram-positive bacterium. Gram-positive bacteria 
have a thick outer peptidoglycan cell wall layer, and this layer takes up the crystal violet and 
confers the purple stain.  
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  Figure 8. Simple stain of S. mutans, confirming the  
  cocci shape of the bacterium and its propensity to 
  form chains.  
 
 
  Figure 9. Gram-stain of S. mutans. The purple color demonstrates  
  that the thick outer peptidoglycan cell wall layer took up the crystal  
  violet dye, which is characteristic of gram-positive organisms.  
 
 
2) Monitoring the Growth of Streptococcus mutans 
 
 The growth of S. mutans was monitored for a period of 24 hours. The absorbance was 
read every hour for the first 10 hours of the growth in nutrient broth, and the absorbance was 
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read every two hours for the first 10 hours for the growth in artificial saliva with different 
concentrations of sucrose. In both cases, a final reading was taken at the 24th hour.  
 A standard growth curve typically displays four distinct stages: the lag phase, the 
exponential growth phase, the stationary phase, and the death phase. The growth of S. mutans 
in nutrient agar demonstrated the first three of these phases over the observed 24 hour period. 
As demonstrated in Figure 10, the lag phase was observed after 1 hour. Then, the exponential 
phase with a constant generation time was observed between 2 and 7 hours, which 
corresponds to the large slope of the graph at this juncture. The stationary phase can be 
observed from hours 7 to 24, as represented by the plateau on the graph. The optical density 
readings at these time points are very similar, suggesting a near equal proportion of cellular 
growth and cellular death. This is due to the nutrients being exhausted by the bacteria in the 
previous hours, causing the cells to die with lack of nourishment. Under optimal conditions, 
the generation time of S. mutans was determined to be 67.5 minutes, based on the equation: g 
= (log10 N1 – log10N0) / log102. This suggests that 67.5 minutes is the time in which this 
bacterium doubles in population size.  
 The growth of S. mutans in artificial saliva with different concentrations of sucrose (0%, 
0.1%, 0.5%, 1%) demonstrated that the bacteria grow most effectively in the presence of 
sucrose. This supports the idea that the cariogenicity of S. mutans corresponds to the 
consumption of carbohydrates, particularly sucrose. The generation time was calculated to be 
170.6 minutes in artificial saliva with 0% sucrose, 76.89 minutes in artificial saliva with 
0.1% sucrose, 94.38 minutes in artificial saliva with 0.5% sucrose, and 89.6 minutes in 
artificial saliva with 1% sucrose. These results are demonstrated in Figure 11. The graph has 
some irregularities compared to a normal growth curve, which may correspond to 
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fluctuations in the nutrients and the uptake of nutrients compared to the standard growth 
curve performed. Further trials should be conducted to understand the reason for some of 
these irregularities, as well as further experiments observing the growth of S. mutans in 
artificial saliva with different concentrations of sucrose.  
 
 
 
 
Figure 10. Standard growth curve for Streptococcus mutans in nutrient broth. The generation time was 
calculated to be 67.5 minutes for the bacterial growth to double. The results were from the mean of three 
repeating trials, and the growth was read at OD600 using a spectrophotometer 
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3) The Effects of Green Tea Polyphenolic Compounds on the Cariogenic S. mutans 
a) Colony Forming Unit Assay 
A CFU assay was performed with the goal of comparing the experimental treatment 
using the tea polyphenols and the control treatment at countable ranges, and using the count 
of colony forming units in order to calculate the percent of inhibition of the green tea 
polyphenols. The experiment was conducted using P-EGCG 250 µg/mL and P-EGCG 500 
µg/mL, and diH2O was utilized as a control. The results demonstrate that P-EGCG at both 
concentrations (250 µg/mL and 500 µg/mL) inhibit the growth of S. mutans, albeit at 
different effectiveness. The percent of inhibition of 250 µg/mL P-EGCG was calculated at 
64.87%, and the percent of inhibition of 500 µg/mL P-EGCG was calculated at 80.58%. 
These results suggest that the green tea polyphenolic compounds are effective in inhibiting 
the growth of the bacteria as opposed to the control which simply contained the cells, tryptic 
Figure 11. Growth curve for Streptococcus mutans in artificial saliva with different sucrose 
concentrations of 0%, 0.1%, 0.5%, and 1%. The generation time was calculated to be 170.6 minutes in 
artificial saliva with 0% sucrose, 76.89 minutes in artificial saliva with 0.1% sucrose, 94.38 minutes in 
artificial saliva with 0.5% sucrose, and 89.6 minutes in artificial saliva with 1% sucrose.  
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soy broth, and diH2O. Dilutions of 10-4 and 10-5 were prepared for the control, and yielded 
average colony forming unit counts of 242 and 31, respectively. Dilutions of 10-2, 10-3, and 
10-4 were prepared for the conditions utilizing tea polyphenolic treatments.  
In both the 250 µg/mL and 500 µg/mL, the 10-2 and 10-3 dilutions yielded extremely high 
counts. The plaque count for 250 µg/mL P-EGCG 10-2 averaged at nearly 1000 plaques over 
two trials, and the count for the 10-3 dilution averaged at 589 plaques over two trials. The 
plaque count for 500 µg/mL P-EGCG 10-2 dilution also averaged at nearly 1000 plaques, and 
the count for the 10-3 dilution averaged at nearly 489 plaques. It appears that 10-4 was the 
appropriate dilution to utilize, as the values were far more countable. For 250 µg/mL P-
EGCG, the plaque count at 10-4 averaged at 86 over two trials. For 500 µg/mL P-EGCG, the 
plaque count at 10-4 averaged at 47 plaques over two trials. The plaque counts for the control 
and treatment plates are demonstrated in Table 2 and Figure 13. The calculated percent of 
inhibition of the 250 µg/mL P-EGCG and 500 µg/mL P-EGCG, compared to the controls at 
this dilution, were 64.87% and 80.58%, respectively, as demonstrated in Figure 12. These 
results suggest that at similar dilutions, P-EGCG strongly inhibits the bacteria and that 500 
µg/mL P-EGCG inhibits the bacteria more effectively than 250 µg/mL P-EGCG. These 
results are shown in Figures 4A and 4B. 
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Treatment/Control 
for S. mutans 
Plaque count, 
Trial 1 
Plaque count, Trial 
2 
Average 
Control 10-4 244 240 242 
Control 10-5 30 32 31 
250 P-EGCG 10-2 ~1000 ~1000 ~1000 
250 P-EGCG 10-3 567 610 589 
250 P-EGCG 10-4 87 85 86 
500 P-EGCG 10-2 ~1000 ~1000 ~1000 
500 P-EGCG 10-3 497 481 489 
500 P-EGCG 10-4 42 52 47 
% inhibition of 250 P-
EGCG  
64.87%   
% inhibition of 500 P-
ECGC 
80.58%   
Table 2. The plaque counts and calculated percent of inhibition of the colony forming unit assay. Two 
trials were conducted, and the averages of each trial were used to calculate the percent of inhibition. 500 
µg/mL P-EGCG inhibits S. mutans more effectively than 250 µg/mL P-EGCG, as they inhibit 80.58% and 
64.87% of the bacteria, respectively.  
 
 
 
 
 
 Figure 12. The percent of inhibition of both concentrations of P-EGCG (250 µg/mL and 500 µg/mL). P-EGCG 500 
µg/mL is more effective in inhibiting S. mutans than P-EGCG 250 µg/mL.  
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b) Time Course Study 
 
 The goal of the time course study was to determine the effectiveness of P-EGCG at 
various time points, as a means of getting insight into the effectiveness of this green tea 
polyphenolic compound as an additive or main ingredient of a potential oral cleanser. 
Though dilutions of 10-2 and 10-4 were prepared, the results for 10-4 suggested that this was 
too much of a dilution, as all of the plates lacked countable plaques. Thus, the results are 
entirely of the dilution factor 10-2. The results of the time course study suggest that P-EGCG 
250 µg/mL inhibits S. mutans growth within artificial saliva with different concentrations of 
sucrose, but the results are mixed. It appears that the inhibitory effects of the treatment 
increase as time goes on, and this difference is especially pronounced in artificial saliva 
without sucrose. After 30 seconds, the green tea compounds inhibited 13.79% of the bacteria, 
but after five minutes this value increased to 72.4% of bacteria. The effectiveness of the 
Figure 13. Demonstration of the results of the CFU assay. The plate on the left demonstrates the 
control plate in which S. mutans was treated with diH2O and then diluted to a factor of 10-4, and the 
plate on the right demonstrates a plate treated with S. mutans and 500 µg/mL P-EGCG and diluted to 
a factor of 10-4. The differences in colony forming units on each plate demonstrates that the green tea 
polyphenols inhibit 80.58% of bacterial growth 
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treatment in this time course study varies between sucrose conditions. The effectiveness is 
limited in the three conditions containing sucrose, as after five minutes only 40% of bacteria 
in saliva with 0.1% sucrose is inhibited, 56.4% of bacteria in saliva with 0.5% sucrose is 
inhibited, and 48.24% of bacteria in saliva with 1% sucrose is inhibited. These values are 
low; repeated trials and different concentrations of both P-EGCG and EGCG-S are required 
to find the optimal treatment for this study. The colony forming unit count is demonstrated in 
Table 3 and the percent of inhibition at each time point is demonstrated graphically in Figure 
14. The plates at each dilution are demonstrated in Figures 15-19. The main takeaway from 
this experiment is that the P-EGCG does inhibit the bacterial growth in artificial saliva with 
different concentrations to some extent, and this inhibitory effect becomes more potent as 
time goes on. It appears that the beneficial effects of sucrose on the growth of S. mutans may 
outweigh the inhibitory effects of 250µg/mL P-EGCG, as the bacteria in greater 
concentrations of sugar are not inhibited nearly as effectively as the bacteria grown without 
sugar. Future studies must also focus on conducting the same study with commercial 
mouthwashes, both independently and in combination with the green tea polyphenolic 
compounds in order to find the most effective oral cleanser. The goal of this study was to 
ultimately compare the effectiveness of mouthwashes to tea treatments at the time points 
studied and then to potentially do a synergistic study of the combined effects of mouthwash 
and tea polyphenols. Although the latter half of the goal was not accomplished, future studies 
should focus on doing so. 
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Treatment (10-2) 30 seconds 1 minute 5 minutes 
Artificial Saliva 0% 
Sucrose Control  
29   
Artificial Saliva 0% 
Sucrose Treated 
25 
 
% inhibition= 13.79% 
20 
 
% inhibition= 31.03% 
8 
 
% inhibition = 72.4% 
Artificial Saliva 
0.1% Sucrose 
Control 
750   
Artificial Saliva 
0.1% Sucrose 
Treated 
570 
 
% inhibition= 24% 
540 
 
% inhibition = 28% 
450 
 
% inhibition= 40% 
Artificial Saliva 
0.5% Sucrose 
Control 
1000   
Artificial Saliva 
0.5% Sucrose 
Treated 
656 
 
% inhibition= 34.4% 
496 
 
% inhibition= 50.4% 
436 
 
% inhibition= 56.4% 
Artificial Saliva 1% 
Sucrose Control 
85   
Artifical Saliva 1% 
Sucrose Treated 
67 
 
% inhibition= 21.18% 
53 
 
% inhibition= 37.65% 
44 
 
% inhibition= 48.24% 
  Table 3. The CFU count and calculated percent of inhibition of the bacteria in different concentrations of 
 sucrose. The dilution factor throughout was 10-2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 Figure 14. A graphical representation of the percent of inhibition of 250 µg/mL  
 P-EGCG at different time points of 30 seconds, 1 minute, and 5 minutes during the time  
 course study  
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Figure 15. The controls used in the study with a dilution factor of 
10-2. The image on the top left corresponds to the bacteria grown in 
0% sucrose, the image on the top right corresponds to the bacteria 
grown in 0.1% sucrose, the image on the bottom left corresponds to 
the bacteria grown in 0.5% sucrose, and the image on the bottom 
right corresponds to the bacteria grown in 1% sucrose. 
Figure 16. The plates of the bacteria treated with 250 µg/mL P-
EGCG at different time points in artificial saliva with 0% sucrose. 
From left to right, this figure shows the effect of 250 µg/mL P-
EGCG on S. mutans grown in artificial saliva without sucrose after 
30 seconds, 1 minute, and 5 minutes. The treatment is more 
effective over time.  
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  Figure 17. The plates of the bacteria treated with 250 µg/mL P-EGCG at  
  different time points in artificial saliva with 0.1% sucrose. From left to right, 
  this figure shows the effect of 250 µg/mL P-EGCG on S. mutans grown in 
  artificial saliva with 0.1% sucrose after 30 seconds, 1 minute, and 5 minutes.  
  The treatment is more effective over time. 
 
 
 
 
  Figure 18. The plates of the bacteria treated with 250 µg/mL P-EGCG at  
  different time points in artificial saliva with 0.5% sucrose. From left to right, 
  this figure shows the effect of 250 µg/mL P-EGCG on S. mutans grown in  
  artificial saliva with 0.5% sucrose after 30 seconds, 1 minute, and 5 minutes.  
  The treatment is more effective over time. 
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  Figure 19. The plates of the bacteria treated with 250 µg/mL P-EGCG at  
  different time points in artificial saliva with 1% sucrose From left to right, this  
  figure shows the effect of 250 µg/mL P-EGCG on S. mutans grown in artificial  
  saliva with 1% sucrose after 30 seconds, 1 minute, and 5 minutes. The treatment  
  is more effective over time. 
 
c) Disk Diffusion Assay 
 
 A disk diffusion assay was conducted in order to compare the inhibitory effects of 
EGCG-S and P-EGCG at both 250 µg/mL and 500 µg/mL to the effects of the four 
aforementioned mouthwash products. A disk diffusion assay results in the clearing of the 
bacterial lawn, and the greater the size of this clearing, the more effective the treatment is at 
inhibiting bacterial growth. The results of this disk diffusion assay demonstrate that the 
commercial mouthwash product Chlorohexidine is most effective against S. mutans, with a 
ZOI measured at 5 mm. Colgate demonstrated a ZOI of 2.5 mm, Dentiste Plus White had a 
ZOI of 1 mm, and Listerine proved to be least effective with a ZOI of 0 mm. The tea 
treatments had similar effectiveness compared to the mouthwashes besides chlorohexidine, 
as EGCG-S 250 µg/mL had a ZOI of 2 mm, EGCG-S 500 µg/mL had a ZOI of 1 mm, P-
EGCG 250 µg/mL had a ZOI of 1 mm, and P-EGCG 500 µg/mL had a ZOI of 0 mm. These 
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results are demonstrated in Table 4 and Figure 20. The results suggest that EGCG-S 250 
µg/mL has a comparable inhibitory effect as Colgate does against S. mutans, and that EGCG-
S 500 µg/mL and P-EGCG 250 µg/mL had a comparable inhibitory effect as Dentiste Plus 
White mouthwash. It also appears EGCG-S is a more effective tea treatment than P-EGCG. 
Future studies should focus on repeated trials, as well as the synergistic effect of the different 
teas and different concentrations of these teas with the mouthwash. Together, these 
treatments could perhaps produce a more effective oral health care mouthwash than the 
majority of the commercially available ones. Listerine particularly demonstrates the greatest 
need for antibacterial additives, such as EGCG-S and P-EGCG, as it did not inhibit the 
growth of S. mutans in this particular assay. The reason P-EGCG has been a treatment of 
focus throughout this study is due to its clearance by the FDA in China as a safe preservative 
in food. This implies that the green tea polyphenolic treatment could perhaps be an effective, 
consumable product for antimicrobial infections, but these results do not suggest its 
effectiveness as an individual product. Future studies should specifically focus on combining 
this treatment with others in hopes of creating an effective, safe to consume product.  
 
Treatment ZOI (mm) 
Chlorohexidine 5 
Colgate 2.5 
Dentiste Plus White 1 
Listerine  0 
EGCG-S 250 µg/mL 2 
EGCG-S 500 µg/mL 1 
P-EGCG 250 µg/mL 1 
P-EGCG 500 µg/mL 0 
Table 4. The ZOI results for the commercial mouthwash brands used as well as the different concentrations of 
EGCG-S and P-EGCG. Chlorohexidine appeared to have the greatest inhibitory effect against the bacterium, 
whereas EGCG-S was comparable or more effective than the rest of the mouthwash brands. P-EGCG 500 250 
µg/mL had a comparable ZOI to Dentiste Plus White, and P-EGCG 500 µg/mL and Listerine did not inhibit the 
growth of the bacteria. 
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 Figure 20. Images of the plates used to conduct the disk diffusion assay utilizing different brands   
 of commercial mouthwash and different concentrations of EGCG-S and P-EGCG. The plate on   
 the left is divided into 4 distinct sections. The section on the top left corresponds to    
 Chlorohexidine, the top right corresponds to Listerine, the bottom left corresponds to Colgate, and  
 the bottom right corresponds to Dentiste Plus White. This plate demonstrates that Chlorohexidine   
 cleared the greatest proportion of bacteria,  followed by Colgate. The plate on the right contains   
 disks soaked in different concentrations of EGCG-S and P-EGCG. The section on the top left   
 corresponds to EGCG-S 250 µg/mL, the section on the right corresponds to EGCG-S 500 µg/mL,   
 the section on the bottom left corresponds to P-EGCG 250 µg/mL, and the section on the bottom   
 right corresponds to P-EGCG 500 µg/mL.  
 
d) Post-Application of P-EGCG and EGCG-S 
 
 The post application experiment was conducted in order to observe the effects of the 
green tea polyphenols after the growth of S. mutans on the agar plates. This perhaps has more 
clinical relevance, as it demonstrates the efficacy of the green tea polyphenols after S. mutans 
has already colonized a site and thus may give insight into the ability of the tea polyphenols 
to treat infection. The results of the post-application suggest great effectiveness of both the 
mouthwashes and the tea treatments against S. mutans growth. Prior to any treatment, the 
plates had a plaque count of 180,000. This value remained constant post-diH2O treatment in 
the control, but the values dropped significantly in each of the treatments. The results are 
shown in Figure 5A-E. Chlorohexidine was the most effective in inhibiting 99.9996% of the 
bacteria on the plate, followed by Colgate, Protect CT, and Listerine, all of which still 
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inhibited at a rate greater than 99.98%. The tea treatments were nearly equally effective, with 
EGCG-S 250 µg/mL and P-EGCG 250 µg/mL inhibiting at over 99% as well. The results of 
this post-application study are reported in Table 5 and the percent of inhibition is 
demonstrated graphically in Figure 21. Figures 22, 23, and 24 demonstrate the plates after the 
application of the green tea polyphenolic compounds. These results indicate great 
effectiveness of the tea polyphenolic compounds, and possibly suggest effectiveness of a 
synergistic treatment of both the mouthwashes and the tea polyphenols.  
 Future studies should focus on conducting a post-application study utilizing the 
mouthwashes and tea polyphenolic compounds synergistically to study whether they inhibit 
the bacteria more effectively than the individual treatment of antibiotics or tea polyphenolic 
compounds. A log reduction calculation was also obtained through an online website. The 
log reduction shows the relative number of bacteria eliminated from the agar plates by the 
treatments. A 1-log reduction corresponds to a ten-fold reduction in bacteria, a 2-log 
reduction corresponds to a 100-fold reduction in bacteria, a 3-log reduction corresponds to a 
1000-fold reduction in bacteria, and so on. Chlorohexidine appears to be the ideal 
mouthwash to test for synergistic effects with the tea polyphenolic compounds, as it has 
proven over several trials of this experiment and the disk diffusion experiment to be the most 
effective of the mouthwashes against S. mutans. The disk diffusion experiment and this post-
application experiment both reveal that 250 µg/mL EGCG-S is more effective than either 
concentration of P-EGCG and that P-EGCG has limited effectiveness compared to the 
mouthwash treatments. Both experiments suggest that perhaps P-EGCG is best suited as an 
additive, and future studies should further investigate this.  
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Treatment (10-4) CFU prior to 
treatment 
CFU post-
treatment 
Percent of 
Inhibition 
Log Reduction 
Control 180,000 180,000 0% 0 
Chlorohexidine 180,000 0.8 99.99955556% 5.35 
Colgate 180,000 8.32 99.99537778% 4.34 
Protect CT 180,000 16.32 99.99093333% 4.04 
Listerine 180,000 32.32 99.98204444% 3.75 
EGCG-S 250 
µg/mL 
180,000 510 99.71666667% 2.55 
EGCG-S 500 
µg/mL 
180,000 2000 98.88888889% 1.95 
P-EGCG 250 
µg/mL 
180,000 1456 99.19111111% 2.09 
P-EGCG 500 
µg/mL 
180,000 2256 98.74666667% 1.9 
Table 5. Results of the post-application treatment of different mouthwashes and tea polyphenols. The results 
include the CFU count of each plate before and after treatment, the calculated percent of inhibition of each 
treatment, and the log reduction of each treatment. Chlorohexidine is the most effective mouthwash against S. 
mutans, inhibiting over 99.999% of the bacteria. EGCG-S 250 µg/mL is the most effective tea treatment, 
inhibiting over 99.7% of the bacteria.  
 
 
 
  
Figure 21. Graphical representation of the percent of inhibition of the treatments used in the post-application. 
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Figure 22. Each of the control plates used. The controls were diluted to 10-4, 10-6, and 10-8, and    they were not 
treated with either mouthwash or tea polyphenols. The controls were instead treated with diH2O. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 23. Mouthwash treated plates at a dilution factor  
of 10-2. Chlorohexidine inhibited the bacteria most  
effectively, followed by Colgate, Protect CT, and Listerine.  
 
 
 
 
Control 10-6 Control 10
-8 
Control 10-4 
 
Chlorohexidine 10-2 
 
Colgate 10-2 
 
Listerine 10-2 
 
Protect CT 10-2 
 
 
EGCG-S 250 µg/mL 10-4 
EGCG-S 500 µg/mL 10-4 
P-EGCG 250 µg/mL 10-4 
P-EGCG 500 µg/mL 10-4 
Figure 24. The post-application plates utilizing EGCG-S 
250 and 500 µg/mL and P-EGCG 250 and 500 µg/mL. 
EGCG-S and P-EGCG 250 µg/mL were most effective in 
inhibiting the bacteria, as they inhibited over 99% of the 
bacteria. 
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4) Treatment of Biofilm with Green Tea Polyphenolic Compounds  
 
a) Congo Red Assay 
 A Congo Red assay was conducted in order to test for the growth of biofilm formation on 
this agar with and without treatment of P-EGCG at both 250 µg/mL and 500 µg/mL. Biofilm 
formation is a typical marker of cavity formation and confers S. mutans several advantages in 
cariogenicity. The results of this qualitative experiment demonstrate that both concentrations 
of P-EGCG, at both 50 µL and 100 µL, inhibited the growth of the biofilm effectively. The 
results of this experiment are demonstrated in Figure 25. The controls demonstrate the dark 
colored accumulation indicative of a positive result of biofilm formation. Congo Red is an 
amyloid binding dye, and when biofilms are produced, amyloid or amyloid-like proteins are 
produced, which bind to the dye and turn the dye black in color. Both concentrations of P-
EGCG appear to have completely inhibited biofilm formation, as evidenced by the strong red 
color of the treated wells. This suggests that P-EGCG actively prevents the formation of the 
slime layer which allows for further adhesion of bacterial cells along with increased 
resistance to suboptimal conditions. Thus, P-EGCG may be able to prevent the formation of 
S. mutans biofilm in the oral cavity, which is typically one of the first signs of dental cavity 
formation. Future studies should evaluate the effects of the different mouthwashes used 
throughout this study on the growth of S. mutans biofilm on Congo Red agar, as the 
prevention of biofilm development is highly significant and would highlight the significance 
of using P-EGCG as an additive to oral cleansers if they are unable to inhibit this growth as 
effectively as the tea polyphenolic compound individually.  
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b) Resazurin and Crystal Violet Assay 
 
 Resazurin and Crystal Violet Assays were conducted several times as another means of 
observing the impact of the green tea polyphenols on the ability of S. mutans to form biofilm. 
Despite the repeated attempts to conduct these experiments, the results were consistently 
false-positives, inconsistent, and counter-intuitive. Before performing each experiment again, 
a qualitative analysis was made of each plate after adding 250 µg/mL and 500 µg/mL of 
EGCG-S and P-EGCG into the plates. This revealed that both concentrations of P-EGCG and 
500 µg/mL EGCG-S resulted in cloudiness and precipitation, which may have interfered with 
the results of each experiment and resulted in the general inconsistency. The cloudiness of 
Control: 50 µL S. mutans 
Control: 100 µL S. mutans 
A 
A B 
B 
A) 100 µL S. mutans + 50 µL  250 
µg/mL P-EGCG 
B) 50 µL S. mutans + 100 µL 250 
µg/mL P-EGCG 
A)100 µL S. mutans + 50 µL  500 
µg/mL P-EGCG 
B) 50 µL S. mutans + 100 µL 500 
µg/mL P-EGCG 
Figure 25. The results of the Congo Red Assay. The control wells developed 
biofilm, as shown by the dark accumulation in each of the wells. The experimental 
wells, in which different 50 µL and 100 µL of 250/500 µg/mL P-EGCG, did not 
develop biofilm, as evidenced by the deep red color of all the wells.  
 53 
the wells treated with both concentrations of P-EGCG and 500 µg/mL EGCG-S can be 
observed in Figure 26, and the precipitation can be observed in the crystal violet dyed wells 
in Figure 27. In Figure 27, the wells with the greatest accumulation at the bottom are those 
treated with P-EGCG, whereas the controls that were not treated with tea had virtually no 
accumulation.  
 The reason for the cloudiness and precipitation need to be investigated further, although it 
appears that these conditions only occur when both concentrations of P-EGCG and 500 
µg/mL of EGCG-S were added to the liquid media. Future studies should look to study the 
effects of the green tea polyphenols on biofilm formation using different studies, such as 
potentially through a fluorescence scope study. This may prove to work more effectively due 
to the fact that solid agar is used in the experiment, similar to the solid agar that proved 
effective in the Congo Red assay.    
 
 
 
       Figure 26. The cloudiness of the wells demonstrates that the tea  
       polyphenolic compounds may be precipitating and accumulating  
        in the solution. This may explain the inconsistencies in the results.  
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   Figure 27. Demonstration of the accumulation of the bottom  
   of the crystal violet plates. There is accumulation on the plates 
   treated with P-EGCG, but no accumulation on the control plates.  
   This gave inconsistent results, because the tea polyphenols should  
    inhibit the growth of biofilm but the absorbance scan showed that  
   the treated wells had greater accumulation.  
 
 
 
5) Effect of EGCG-S on ESKAPE Pathogens 
 
a) Gram-Stain Results 
 
 A gram-stain was conducted of the ESKAPE organisms to characterize each bacterium. 
The results confirm that Enterococcus faecalis and Staphylococcus aureus are gram-positive 
bacterium, as evidenced by the dark purple stain observed in Figure 28A and 28B. The gram-
stain also confirmed that Klebsiella pneumoniae, Pseudomonas aeruginosa, and 
Enterobacter species are gram-negative species, as evidenced by the light pink hue of the 
stained cells. These results are shown in Figure 28 C-E. The gram-negative bacteria are 
stained pink because they have an extra layer made up of lipopolysaccharides and proteins, 
and thus they take up the safranin, resulting in the pink color.  
 55 
 
 
 
 
 
 
 
 
b) Disk Diffusion Results  
 
 The disk diffusion experiments were conducted on each of the ESKAPE bacteria in order 
to test for the synergistic effects of EGCG-S with the antibiotics. Considering these bacteria 
are associated with increasing antibiotic resistance, any treatment that could increase the 
effectiveness of the antibiotics against these bacteria is worth investigating. The results of the 
disk diffusion assay of the ESKAPE bacteria indicate that 500 µg/mL EGCG-S is able to 
inhibit the growth of each individual bacteria, as evidenced by the comparison of the blank 
disk and the blank disk treated with EGCG-S. The results of the synergistic effects of the 
Figure 28. Gram-stain results of the ESKAPE pathogens. (A) The purple stain of E. faecalis cells 
confirms that the organism is gram-positive. (B) The purple stain of S. aureus cells confirms that 
the organism is gram-positive. (C) The pink stain of K. pneumoniae confirms that the organism is 
gram-negative. (D) The pink stain of P. aeruginosa confirms the organism is gram-negative. (E) 
The pink stain of Enterobacter species confirms the organism is gram-negative. 
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antibiotics and 500 µg/mL EGCG-S vary for each organism. An organism’s response to an 
antibiotic can be described as being resistant, intermediately resistant, or sensitive, and the 
synergistic treatment of the tea conferred increase resistance to certain antibiotics in each 
organism compared to the effects of the antibiotic alone. Each organism’s resistance profile 
to the antibiotics is based on the zone of inhibition, and thus the ability of EGCG-S to 
synergistically create a larger zone of inhibition than the antibiotic alone correlates to the 
bacteria being more sensitive to this treatment.  
 For E. faecalis, the status of this bacterium with regards to Kanamycin changed from 
resistant to intermediately resistant and from resistant to sensitive with regards to 
Streptomycin. These results for E. faecalis are shown in Figures 29-30. The bacterium S. 
aureus appeared sensitive most of the antibiotics without the treatment of green tea 
polyphenols, and thus the synergistic treatment only slightly increased the effectiveness of 
the antibiotics. The most promising effect of EGCG-S was in changing the status of S. aureus 
from intermediately resistant to Vancomycin to sensitive to it. The results for S. aureus are 
demonstrated in Figures 31-32. The effect of EGCG-S on the antibiotic resistance of K. 
pneumoniae and P. aeruginosa was far more pronounced. K. pneumoniae was initially 
resistant to Erythromycin, Penicillin, and Bacitracin, but treatment with the antibiotic and 
100 µL of EGCG-S made this bacterium only intermediately resistant. The combined 
treatment also changed K. pneumoniae from being resistant to Vancomycin and Cephalothin 
to being fully sensitive to the treatment. The results for K. pneumoniae are reported in 
Figures 33-34. Though P. aeruginosa showed resistance to Chloramphenicol, Penicillin, 
Ampicillin, Streptomycin, and Bacitracin, the combined treatment with EGCG-S changed the 
status of this bacterium to intermediately resistant to these antibiotics. This bacterium also 
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changed from being resistant to Vancomycin and Polymyxin individually to being 
completely sensitive to both antibiotics when treated with the tea polyphenols. The results for 
P. aeruginosa are shown in Figure 35-36. Lastly, Enterobacter species showed intermediate 
resistance to Chloramphenicol and Polymyxin individually, but when synergistically treated 
with these antibiotics and 500 µg/mL EGCG-S, they showed sensitivity to both. The results 
for Enterobacter spp. are shown in Figures 37-38.  
 The combined treatment of EGCG-S and the antibiotics proved effective in more cases 
than the aforementioned examples, but they did not result in changes to each bacteria’s drug 
susceptibility. However, it is still significant that EGCG-S increase the effectiveness of those 
antibiotics. Ultimately, the disk diffusion study demonstrates that EGCG-S is effective in 
increasing the impact of several antibiotics against a group of organisms becoming 
increasingly resistant to drugs. Should this resistance increase even further in the coming 
years, there will be an increasing demand for different approaches to inhibit the growth and 
proliferation of bacteria, particularly the ESKAPE pathogens. Thus, EGCG-S can perhaps 
offer a solution to control ESKAPE infections and limit the principal cause of nosocomial 
infections. Future studies should aim to conduct repeating trials, include more antibiotics, 
and also utilize more concentrations of EGCG-S in order to find the optimal treatment to use 
synergistically with the antibiotics. The results for Enterobacter spp. were inconsistent, and 
future studies should focus on this bacterium specifically.  
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  Figure 29. A graphical representation of the inhibitory effect of the antibiotics, individually (bar  
  on the left) and synergistically with 500 µg/mL EGCG-S (bar on the right). The greatest impact of  
  the synergistic treatment is observed in Kanamycin and Streptomycin, as the bacteria changed  
  from resistant to intermediately resistant (Kanamycin) and sensitive (Streptomycin) 
 
 
 
 
 
 
  Figure 30. A graphical representation of the percent of increase/decrease of the zone of inhibition  
  of the synergistic treatment compared with the individual treatment of antibiotics for E. faecalis.  
  
Resistant  
Intermediate 
Sensitive 
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 Figure 31. A graphical representation of the inhibitory effect of the antibiotics, individually (bar   
 on the left) and synergistically with 500 µg/mL EGCG-S (bar on the right). The bacterium was  
 sensitive to all of the antibiotics except Vancomycin, and the synergistic treatment caused S. aureus  
 to be sensitive to Vancomycin as well. 
  
 
 
 
 
  Figure 32. A graphical representation of the percent of increase/decrease of the zone of inhibition  
  of the synergistic treatment compared with the individual treatment of antibiotics for S. aureus.  
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  Figure 33. A graphical representation of the inhibitory effect of the antibiotics, individually (bar  
  on the left) and synergistically with 500 µg/mL EGCG-S (bar on the right). K. pneumoniae was  
  resistant to Erythromycin, Penicillin, Bacitracin, Vancomycin, and Cephalothin, but the   
  synergistic treatment made the bacterium more sensitive to these. The synergistic treatment made  
  the bacterium intermediately resistant to Erythromycin, Penicillin, and Bacitracin, and sensitive to  
  Vancomycin and Cephalothin 
 
  
 
 
 
 
 
  Figure 34. A graphical representation of the percent of increase/decrease of the zone of inhibition  
  of the synergistic treatment compared with the individual treatment of antibiotics for K.   
  pneumoniae 
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  Figure 35. A graphical representation of the inhibitory effect of the antibiotics, individually (bar  
  on the left) and synergistically with 500 µg/mL EGCG-S (bar on the right). P. aeruginosa was  
  resistant to Chloramphenicol, Penicillin, Ampicillin, Streptomycin, Bacitracin, Vancomycin, and  
  Polymyxin, but the synergistic treatment made the bacterium more sensitive to these. The  
  synergistic treatment made the bacterium intermediately resistant to Chloramphenicol, Penicillin,  
  Ampicillin, Streptomycin, and Bacitracin, and the treatment made the bacterium sensitive to  
  Vancomycin and Polymyxin.  
 
 
 Figure 36. A graphical representation of the percent of increase/decrease of the zone of inhibition   
 of the synergistic treatment compared with the individual treatment of antibiotics for P. aeruginosa 
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           Figure 37. A graphical representation of the inhibitory effect of the antibiotics, individually (bar  
           on the left) and synergistically with 500 µg/mL EGCG-S (bar on the right). The results were mixed,  
           but the bacteria changed from being intermediately resistant to Chloramphenicol and Polymyxin to  
           sensitive to both when synergistically treated with these antibiotics and EGCG-S.  
 
 
 
 
  Figure 38. A graphical representation of the percent of increase/decrease of the zone of inhibition  
  of the synergistic treatment compared with the individual treatment of antibiotics. Further trials  
  need to be conducted to ascertain the results, as it appears that the synergistic treatment worked  
  less effectively than several individual antibiotics, including Vancomycin, Ampicillin, Bacitracin,  
  and Cephalothin 
 
 
 
Resistant  
Intermediate 
Sensitive 
 63 
c) Colony Forming Unit Assay 
 
 The results of the colony forming unit assay demonstrate that both 250 and 500 µg/mL 
EGCG-S are effective in inhibiting the growth of the ESKAPE pathogens, though the degree 
to which they inhibit the bacteria is mixed. A 10-2 dilution factor was utilized throughout, as 
the countable range was ideal. The effects of the green tea polyphenols were not very potent 
against E. faecalis as compared to its effects on other bacteria, as both concentrations 
inhibited 32% of the bacterial growth. The percent of inhibition is demonstrated graphically 
in Figure 39. The results for the use of EGCG-S against S. aureus suggest that 250 µg/mL 
EGCG-S is more effective than 500 µg/mL EGCG-S, as these concentrations of EGCG-S 
inhibited 77.1% and 70.15%, respectively. The results for the percent of inhibition of S. 
aureus is reported graphically in Figure 40. However, the opposite observation was observed 
for K. pneumoniae, as 500 µg/mL EGCG-S was more effective in inhibiting bacterial growth 
than 250 µg/mL EGCG-S. The percent of inhibition for 250 µg/mL EGCG-S was 32%, and 
the percent of inhibition for 500 µg/mL EGCG-S was 43%. These results are demonstrated in 
Figure 41. The use of 250 µg/mL and 500 µg/mL EGCG-S against P. aeruginosa inhibited 
55.55% and 61.73% of bacterial growth, respectively. These results are shown in Figure 42. 
Lastly, the use of 250 µg/mL EGCG-S was the most effective on Enterobacter species 
compared to any of the concentrations of EGCG-S used on the ESKAPE pathogens, 
inhibiting 78.50% of bacterial growth. These results are reported in Figure 43.  
 Though the results do report bacterial growth inhibition, repeating trials should be 
conducted to confirm these results. With regards to Enterobacter spp., 500 µg/mL EGCG-S 
should be utilized to study its effectiveness compared to 250 µg/mL EGCG-S, which was 
relatively effective.  
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Figure 39. A graphical representation demonstrating the percent of inhibition of each 
concentration of EGCG-S against the growth of E. faecalis. Both concentrations 
limited growth at equal strength, inhibiting 32% in both cases.  
Figure 40. A graphical representation demonstrating the percent of inhibition of each 
concentration of EGCG-S against the growth of S. aureus. 250 µg/mL EGCG-S 
inhibited growth more effectively than 500 µg/mL EGCG-S, with the percent of 
inhibition being 77.1% and 70.15%, respectively 
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Figure 41. A graphical representation demonstrating the percent of inhibition of each 
concentration of EGCG-S against the growth of K. pneumoniae. 500 µg/mL EGCG-S 
inhibited growth more effectively than 250 µg/mL EGCG-S, with the percent of 
inhibition being 43 EGCG % and 32%, respectively 
Figure 42. A graphical representation demonstrating the percent of inhibition of each 
concentration of EGCG-S against the growth of P. aeruginosa. 500 µg/mL EGCG-S 
inhibited growth more effectively than 250 µg/mL EGCG-S, with the percent of 
inhibition being 61.73% and 55.55%, respectively 
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Conclusions 
 In conclusion, it appears that EGCG-S and P-EGCG are effective in inhibiting the growth 
of S. mutans, as demonstrated in the colony forming unit assay, the time course study, the disk 
diffusion assay, and the post-application treatment of the green tea polyphenolic compounds. The 
colony forming unit assay demonstrated that 250 µg/mL P-EGCG inhibited 64.87% of S. mutans 
growth and 500 µg/mL P-EGCG inhibited 80.58% of bacterial growth. A time course study was 
conducted in order to observe the effects of P-EGCG over different time points of 30 seconds, 1 
minute, and 5 minutes, and the results were mixed. Though the experiment did demonstrate that 
the green tea polyphenol treatment was more effective at the later time points, suggesting that the 
treatment needs longer exposure to the bacterial cells to increase effectiveness, the inhibition of 
the bacteria was not very pronounced. The treatment was most effective after 5 minutes in the 
artificial saliva with 0% sucrose condition, suggesting that the beneficial effects of added sucrose 
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Figure 43. A graphical representation demonstrating the percent of inhibition of each 
concentration of EGCG-S against the growth of Enterobacter spp. Though only 
results for 250 µg/mL EGCG-S were gathered, this concentration inhibited bacterial 
growth more than any concentration of EGCG-S did any other ESKAPE organism at 
78.5%. 
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on bacterial growth may be greater than the inhibitory effects of P-EGCG against S. mutans. 
However, because cloudiness and precipitation were observed when P-EGCG was inoculated 
into the media mixture of artificial saliva and tryptic soy broth in the case of the Resazurin and 
Crystal Violet assays, it is possible that this phenomenon occurred and skewed these results. One 
of the goals of the experiments with S. mutans and the green tea polyphenols was to observe its 
effectiveness compared to several mouthwash brands with the hopes of P-EGCG being more 
effective than the mouthwash brands or potentially suitable as an additive to them. The disk 
diffusion assay and post-application treatment investigated this phenomenon, and revealed that 
Chlorohexidine was the most effective treatment of all in both experiments. It inhibited over 
99.7% of bacterial growth in the post-application experiment and created a zone of inhibition 
twice as large as the next best treatment, Colgate. 250 µg/mL EGCG-S demonstrated similar 
effectiveness to Colgate and proved more effective than both Listerine and Dentiste Plus White, 
and 250 µg/mL P-EGCG was more effective than Listerine in the disk diffusion assay. However, 
the results of these two studies suggest that P-EGCG is not more effective as an individual agent 
than the tested mouthwashes, and thus it may be better suited as an additive to other oral 
cleansing agents as opposed to an individual treatment.  
 The results of the Congo Red, Resazurin, and Crystal Violet assays were mixed. The 
control wells of the Congo Red assay demonstrated dark accumulation on the wells, suggesting 
the growth of biofilm after incubation for 3-4 days. The wells treated with both S. mutans 
cultures and both concentrations of EGCG-S and P-EGCG were a deep red color, suggesting 
complete inhibition of biofilm formation. This is very promising considering that biofilm 
formation is an early marker of dental cavity formation. However, the results of the Resazurin 
and Crystal Violet assays were inconsistent, and a qualitative analysis of the wells showed 
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cloudiness and precipitation. This may have been due to the reaction of P-EGCG and 500 µg/mL 
EGCG-S with the liquid media, and this was observed over several trials. The reason for this 
precipitation is unknown at this point, and must be investigated further.  
 S. mutans is the main etiological cause of dental caries due to its ability to utilize 
carbohydrates like sucrose and produce acid end-products that wear away at the enamel. The 
experiments conducted sought to limit the growth of S. mutans with P-EGCG, an esterified 
derivative of EGCG that has been approved by the FDA in China for consumption. Experiments 
were conducted in tryptic soy broth, in artificial saliva containing different concentrations of 
sucrose, and in comparison to four different mouthwash products. Overall, the results of the S. 
mutans study suggest that P-EGCG is effective in inhibiting the bacterial growth, but EGCG-S 
may be more effective and neither treatment appears to be more effective than available 
mouthwash treatments. Though these treatments do have benefits as organic, herbal remedies, 
they do not appear to be better suited as individual treatments. However, their role as synergistic 
agents may be more impactful.  
 The results of the ESKAPE study suggest that EGCG-S is effective in inhibiting the 
growth of each organism, as evidenced by the colony forming unit study. However, the degree of 
inhibition varied greatly between each organism, and repeated trials are necessary to ascertain 
the extent to which EGCG-S impacts the growth of each organism. The issue with the ESKAPE 
pathogens is their growing resistance to antibiotics, and thus the disk diffusion assay investigated 
whether 500 µg/mL EGCG-S could increase each organism’s sensitivity to antibiotics. As each 
organism becomes more resistant to antibiotics, alternative treatments are needed in order to 
control this issue, as the ESKAPE pathogens are a principal cause of nosocomial infections and 
threaten to become more problematic as time goes on. The results of the disk diffusion assay 
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demonstrate that treatment of the antibiotics with EGCG-S increases each organism’s sensitivity 
to select antibiotics. E. faecalis was originally resistant to Kanamycin and Streptomycin, but 
treatment with EGCG-S made this organism intermediately resistant to Kanamycin and sensitive 
to Streptomycin. Treatment with EGCG-S changed the susceptibility of S. aureus to Vancomycin 
from intermediately resistant to sensitive. K. pneumoniae was originally resistant to 
Erythromycin, Penicillin, Bacitracin, Vancomycin, and Cephalothin, but after treatment with 
EGCG-S, the bacterium became intermediately resistant to Erythromycin, Penicillin and 
Bacitracin, and became sensitive to Vancomycin and Cephalothin. P. aeruginosa was resistant to 
Chloramphenicol, Penicillin, Ampicillin, Streptomycin, Bacitracin, Vancomycin, and 
Polymyxin, but treatment with EGCG-S made this bacterium intermediately resistant to 
Chloramphenicol, Penicillin, Ampicillin, Streptomycin and Bacitracin, and sensitive to 
Vancomycin and Polymyxin. Lastly, Enterobacter species was intermediately resistant to 
Chloramphenicol, but treatment with the green tea polyphenolic compound made this bacterium 
sensitive to this drug. These results suggest that EGCG-S may be an effective additive to 
antibiotics to combat the drug resistance development of the ESKAPE bacterium.  
 
 
Future Studies and Implications 
 
 With regards to the study on the growth of S. mutans, future studies should focus on 
repeating trials of each experiment in order to ascertain that the results are accurate. Though 
three trials were typically conducted for each, it is worth investigating further. Future studies 
should also aim to further compare the effectiveness of mouthwash products (both in terms of the 
mouthwashes used in this study and more mouthwash products). The purpose of the experiments 
with the mouthwash was to observe if the green tea polyphenolic compounds, particularly P-
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EGCG, could perhaps serve as a more effective alternate to commercial brands of mouthwash. 
Thus, further experimentation should be performed to see if this is the case, and future studies 
should also focus on synergistic treatments of mouthwash and P-EGCG. Chlorohexidine appears 
to be the most effective mouthwash product that was tested and Listerine inhibited the growth 
least effectively of the mouthwashes, but perhaps both products could be more effectively with 
P-EGCG included as an additive. The time course study in particular should continue to be 
tested, as this experiment could give the most insight into the effects of P-EGCG as an individual 
or synergistic oral cleansing agent. Overall, more synergistic studies utilizing both P-EGCG and 
mouthwash products need to be conducted in the hopes of discovering a more effective oral 
cleansing product than commercially available ones. Further experiments must also be conducted 
within artificial saliva at different concentrations of sucrose to emulate the oral cavity after sugar 
consumption. The viability of P-EGCG as a safe-to-consume product must also be investigated 
further, as well as its effects in vivo to determine if the effects of P-EGCG are as promising 
within the oral cavity as they appear to be within a lab setting.  
 Future experiments should aim to investigate the phenomenon observed during the 
Resazurin and Crystal Violet assays for analyzing the growth of biofilm. Whereas the Congo 
Red experiment demonstrated that P-EGCG inhibited the growth of S. mutans biofilm, the 
Resazurin and Crystal Violet assays gave inconclusive, inconsistent results due to apparent 
cloudiness and precipitation. It appears that both concentrations of P-EGCG and 500 µg/mL 
EGCG-S react poorly with the liquid media, whether it be the artificial saliva or the tryptic soy 
broth, and the reason for this cloudiness and precipitation must be understood. Other experiments 
to study the effects of P-EGCG and EGCG-S on biofilm growth should be conducted using solid 
agar, such as a fluorescence scope study. 
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 Future studies on the ESKAPE pathogens should include repeated trials of both the 
colony forming unit assay and the disk diffusion experiment, as well as a greater range of 
experiments, potentially including synergistic CFU experiments including EGCG-S and 
antibiotics. A greater range of antibiotics could also be investigated. The purpose of 
experimenting with antibiotics and EGCG-S was to study if EGCG-S could make the ESKAPE 
bacteria more sensitive to antibiotics. Though the disk diffusion studies did demonstrate the 
effectiveness of EGCG-S in making the bacteria more sensitive to various antibiotics, it is worth 
investigating this phenomenon over repeated trials, over more experiments, and with a greater 
range of antibiotics.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 72 
References:  
 
Aframian, D. J., Davidowitz, T., & Benoliel, R. (2006). The distribution of oral mucosal  pH 
 values in healthy saliva secretors. Oral diseases, 12(4), 420-423. 
 
Ajdic D, McShan WM, McLaughlin RE, Savic G, Chang J, Carson MB, Primeaux C, Tian 
 RY, Kenton S, Jia HG, Lin SP, Qian YD, Li SL, Zhu H, Najar F, Lai HS, White J, 
 Roe BA, Ferretti JJ. (2002). Genome sequence of Streptococcus mutans UA159, a 
 cariogenic dental pathogen. PNAS. 99:14434–14439. 
 
Biswas, S., Rithesh, K., Savita, S., & Shivaprasad, B. (2015). Comparative evaluation of the 
 effect of Green tea, Listerine and Chlorhexidine mouth washes in gingivitis patients: A 
 randomized controlled trial. Scholars Journal of Dental Sciences, 2(1), 104-112. 
 
Bender, G. R., Sutton, S. V., & Marquis, R. E. (1986). Acid tolerance, proton permeabilities, and 
 membrane ATPases of oral streptococci. Infection and Immunity, 53(2), 331–338. 
 
Berman, K., Gibbons, R., & Nalbandian, J. (1967). Localization of intracellular polysaccharide 
 granules in Streptococcus mitis. Archives of Oral Biology, 12(10).  
 
Bodonakik  N. C., King S. D., Narla V. R. (1984). Antimicrobial resistance in clinical isolates  of  
 Staphylococcus aureus at the University  Hospital of the West  Indies. The West Indian 
 Medical Journal.  
 73 
Boucher, H., Talbot, G., Bradley, J., Edwards, J., Gilbert, D., Rice, L., . . . Bartlett, J. (2009). 
 Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of 
 America. Clinical Infectious Diseases, 48(1), 1-12. 
 
Chen, P., Tan, Y., Sun, D., & Zheng, X. (2003). A novel long-chain acyl-derivative of 
 epigallocatechin-3-O-gallate prepared and purified from green tea polyphenols. Journal 
 of Zhejiang University SCIENCE, 4(6), 714. 
 
Chen, P., Dickenson, D., & Hsu, S. (2009). Lipid-soluble green tea polyphenols: Stabilized for 
 effective formulation. Handbook of Green Tea & Health Research, 48(3). 
 
Durso, S., Vieira, L., Cruz, J., Azevedo, C., Rodrigues, P., & Simionato, M. (2014). Sucrose 
 Substitutes Affect the Cariogenic Potential of Streptococcus mutans Biofilms. Caries 
 Research,48(3), 214-222.  
 
Forssten, S. D., Björklund, M., & Ouwehand, A. C. (2010). Streptococcus mutans, Caries and 
 Simulation Models. Nutrients, 2(3), 290–298.  
 
Fukuoka, T., Ohya, S., Narita, T., Katsuta, M., Iijima, M., Masuda, N., … Nikaido, H. (1993). 
 Activity of the carbapenem panipenem and role of the OprD (D2) protein in its diffusion 
 through the Pseudomonas aeruginosa outer membrane. Antimicrobial Agents and 
 Chemotherapy, 37(2), 322–327. 
 
 74 
Gao, X., Jiang, S., Koh, D., & Hsu, C. Y. S. (2016). Salivary biomarkers for dental caries. 
 Periodontology 2000, 70(1), 128-141. 
 
Giedraitienė, A., Vitkauskienė, A., Naginienė, R., & Pavilonis, A. (2011). Antibiotic Resistance 
 Mechanisms of Clinically Important Bacteria. Medicina, 47(3), 137-146.  
 
Griswold, A. R., Chen, Y.-Y. M., & Burne, R. A. (2004). Analysis of an Agmatine Deiminase 
 Gene Cluster in Streptococcus mutans UA159. Journal of Bacteriology, 186(6), 1902–1
 904.  
 
Gupta, P., Gupta, N., Pawar, A. P., Birajdar, S. S., Natt, A. S., & Singh, H. P. (2013). Role of 
 Sugar and Sugar Substitutes in Dental Caries: A Review. ISRN Dentistry, 1-5. 
 
Hamilton-Miller JMT. (2001). Anti-cariogenic effects of tea (Camellia sinensis) Journal  of 
 Medical Microbiology. 50:299–302. 
 
Hirasawa, M., Takada, K., Makimura, M., & Otake, S. (2002). Improvement of periodontal 
 status by green tea catechin using a local delivery system: A clinical pilot study. Journal 
 of Periodontal Research, 37(6), 433-438.  
 
Hirasawa, M., & Takada, K. (2004). Multiple effects of green tea catechin on the antifungal 
 activity of antimycotics against Candida albicans. Journal of Antimicrobial 
 Chemotherapy, 53(2), 225-229.  
 75 
 
Hirasawa, M., Takada, K., & Otake, S. (2006). Inhibition of Acid Production in Dental Plaque 
 Bacteria by Green Tea Catechins. Caries Res Caries Research, 40(3), 265-270.   
 
Houang, E. T., Sormunen, R. T., Lai, L., Chan, C. Y., & Leong, A. S. (1998). Effect of 
 desiccation on the ultrastructural appearances of Acinetobacter baumannii and 
 Acinetobacter lwoffii. Journal of Clinical Pathology, 51(10), 786–788. 
 
Indrawattana, N., Sungkhachat, O., Sookrung, N., Chongsa-Nguan, M., Tungtrongchitr, A., 
 Voravuthikunchai, S. P., . . . Chaicumpa, W. (2013). Staphylococcus aureus clinical 
 Isolates: Antibiotic Susceptibility, Molecular Characteristics, and Ability to Form 
 Biofilm. BioMed Research International, 2013, 1-11. 
 
Klimek, J., Hellwig, E., & Ahrens, G. (1982). Fluoride Taken Up by Plaque, by the Underlying 
 Enamel and by Clean Enamel from Three Fluoride Compounds in vitro. Caries 
 Research, 16(2), 156-161. 
 
Kolenbrander, E., Jakubovics, N.S., Chalmers, N.I., Palmer, R.J. (2007). Human Oral Multi-
 species Biofilms: Bacterial Communities in Health and Disease. The Biofilm Mode of 
 Life: Mechanisms and Adaptations.  
 
 76 
Krzyściak, W., Jurczak, A., Kościelniak, D., Bystrowska, B., & Skalniak, A. (2013). The 
 virulence of Streptococcus mutans and the ability to form biofilms. European Journal of 
 Clinical Microbiology & Infectious Diseases, 33(4), 499-515.  
 
Lee, L. H., & Chu, T. (2015). Microbiological Laboratory Manual. Plymouth, MI: Hayden-
 McNeil Publishing.  
 
Li, X.-Z., & Nikaido, H. (2009). Efflux-Mediated Drug Resistance in Bacteria: an 
 Update. Drugs, 69(12), 1555–1623.  
 
Loesche, W. J. (1986). Role of Streptococcus mutans in human dental decay. Microbiological 
 Reviews, 50(4), 353–380. 
 
Loesche, WJ. (1996).  Microbiology of Dental Decay and Periodontal Disease. editor. Medical 
 Microbiology. 
 
Magill, S. S., Edwards, J. R., Bamberg, W., Beldavs, Z. G., Dumyati, G., Kainer, M. A., . . . 
 Fridkin, S. K. (2014). Multistate Point-Prevalence Survey of Health Care–Associated 
 Infections. New England Journal of Medicine,370(13), 1198-1208. 
 
Makimura, M., Hirasawa, M., Kobayashi, K., Indo, J., Sakanaka, S., Taguchi, T., & Otake, S. 
 (1993). Inhibitory Effect of Tea Catechins on Collagenase Activity. Journal of 
 Periodontology, 64(7), 630-636.  
 77 
 
Mandel, I. D. (1974). Relation of Saliva and Plaque to Caries. Journal of Dental Research, 53(2), 
 246-266. 
 
Mankovskaia, A., Lévesque, C. M., & Prakki, A. (2013). Catechin-incorporated dental 
 copolymers inhibit growth of Streptococcus mutans. J. Appl. Oral Sci. Journal of Applied 
 Oral Science, 21(2), 203-207.  
 
Mclaren, L., Mcneil, D. A., Potestio, M., Patterson, S., Thawer, S., Faris, P., . . . Shwart, L. 
 (2016). Equity in children’s dental caries before and after cessation of community water 
 fluoridation: differential impact by dental insurance status and geographic material 
 deprivation. International Journal for Equity in Health,15(1). 
 
Minah, G. E. & Loesche W. J. (1977). Sucrose Metabolism in Resting-Cell Suspensions of 
 Caries-Associated and Non-Caries-Associated Dental Plaque. Infection and Immunity, 
 p.43-57.  
 
Nakane, H., Fukushima, M., & Ono, K. (1990). Differential Inhibition of Reverse Transcriptase 
 and Various DNA Polymerases by Digallic Acid and Its Derivatives. Journal of Natural 
 Products, 53(5), 1234-1240. 
 
Nakayama, M., Toda, M., Okubo, S., & Shimamura, T. (1990). Inhibition of influenza virus 
 infection by tea. Letters in Applied Microbiology, 11(1), 38-40. 
 78 
 
Nomura, L. H., Bastos, J. L., & Peres, M. A. (2004). Dental pain prevalence and association with 
 dental caries and socioeconomic status in schoolchildren, Southern Brazil, 
 2002. Brazilian Oral Research,18(2), 134-140. 
 
Oda, Y., Hayashi, F., & Okada, M. (2015). Longitudinal study of dental caries incidence 
 associated with Streptococcus mutans and Streptococcus sobrinus in patients with 
 intellectual disabilities. BMC Oral Health,15(1).  
 
Otake S, Makimura M, Kuroki T, Nishihara Y, Hirasawa M. (1991). Anticaries effects of 
 polyphenolic compounds from Japanese green tea. Caries Research. 25:438–443. 
 
Ovidiu Peneş, Nicolae & Muntean, Alexandru & Moisoiu, Adriana & Muntean, Mădălina & 
 Chirca, Alexandru & Alexandru Bogdan, Miron & Popa, Mircea Ioan. (2017). An 
 overview of resistance profiles ESKAPE pathogens from 2010-2015 in a tertiary 
 respiratory center in Romania.  
 
Prescott, L. M., Harley, J. P., Klein, D. A., Willey, J. M., Sherwood, L. M., & Woolverton, C. J. 
 (2008). Microbiology. Estados Unidos: McGraw-Hill. 
 
Quivey, R. G., Kuhnert, W. L., & Hahn, K. (2001). Genetics of Acid Adaptation in Oral 
 Streptococci. Critical Reviews in Oral Biology & Medicine, 12(4), 301-314. 
 
 79 
 
Rebelo, M. A., Cardoso, E. M., Robinson, P. G., & Vettore, M. V. (2015). Demographics, social 
 position, dental status and oral health-related quality of life in community-dwelling older 
 adults. Quality of Life Research,25(7), 1735-1742.  
 
Rugg-Gunn, A., Hackett, A., Appleton, D., Jenkins, G., & Eastoe, J. (1984). Relationship 
 between dietary habits and caries increment assessed over two years in 405 English 
 adolescent school children. Archives of Oral Biology, 29(12), 983-992. 
 
Saini, R., Saini, S., & Sharma, S. (2011). Biofilm: A dental microbial infection. Journal  of 
 Natural Science, Biology, and Medicine, 2(1), 71–75. 
 
Sakanaka S, Kim M, Taniguchi M, Yamamoto T. (1989) Antibacterial substances in Japanese 
 green tea extract against Streptococcus mutans, a cariogenic bacterium. Agricultural and 
 Biological Chemistry. 53:2307–2311. 
 
Santajit, S., & Indrawattana, N. (2016). Mechanisms of Antimicrobial Resistance in ESKAPE 
 Pathogens. BioMed Research International, 2016, 1-8. 
 
Sheiham, A. (1984). Changing Trends in Dental Caries. International Journal of 
 Epidemiology, 13(2), 142-147. 
 
 80 
Shigeyuki Hamada, Suzanne M. Michalek, et al. (1986). Molecular Microbiology and 
 Immunobiology of Streptococcus mutans. New York: Elsevier Science. 
 
Streaking and Isolating Bacteria on an LB Agar Plate. (n.d.). Retrieved from 
 https://www.addgene.org/protocols/streak-plate/ 
 
Taylor, P. W., Hamilton-Miller, J. M. T., & Stapleton, P. D. (2005). Antimicrobial 
 properties of green tea catechins. Food Science and Technology Bulletin, 2, 71– 81. 
 
Tinanoff, N. (2017). Individuals Who Brush Their Teeth Infrequently May Be at Greater Risk 
 for New Carious Lesions. Journal of Evidence Based Dental Practice,17(1), 51-52.  
 
Top, J., Willems, R., Velden, S. V., Asbroek, M., & Bonten, M. (2007). Emergence of Clonal 
 Complex 17 Enterococcus faecium in The Netherlands. Journal of Clinical 
 Microbiology, 46(1), 214-219. 
 
Trahan, L., Bareil, M., Gauthier, L., & Vadeboncoeur, C. (1985). Transport and Phosphorylation 
 of Xylitol by a Fructose Phosphotransferase System in Streptococcus mutans. Caries 
 Research, 19(1), 53-63. 
 
Wilson, D. N. (2014). Ribosome-targeting antibiotics and mechanisms of bacterial 
 resistance. Nature Reviews Microbiology, 12(1), 35-48. 
 
 81 
Wright, G. (2005). Bacterial resistance to antibiotics: Enzymatic degradation and 
 modification. Advanced Drug Delivery Reviews, 57(10), 1451-1470. 
 
Wu-Yuan, C., Chen, C., & Wu, R. (1988). Gallotannins Inhibit Growth, Water-insoluble Glucan 
 Synthesis, and Aggregation of Mutans Streptococci. Journal of Dental Research, 67(1), 
 51-55. 
 
Xu, Xin. Zhou D. Xue. Wu, Christine D. (2012).  Tea catechin epigallocatechin gallate inhibits 
 Streptococcus mutans biofilm formation by suppressing gtf genes.  Archives of Oral 
 Biology. 57: 678-683 
 
 
 
 
 
 
 
 
 
 
 
